Patient Price Information List
Disclaimer: Harbor Regional Health determines its standard charges for patient items and services through the use of a chargemaster system, which is a list of charges for the components of patient care that go into every patient’s bill. These are the baseline rates for items and services provided at the Hospital. The chargemaster is similar in concept to the manufacturer’s suggested retail price (“MSRP”) on a particular product or good. The charges listed provide only a general starting point in determining the potential costs of an individual patient’s care at the Hospital. This list does not reflect the actual out-of-pocket costs that may be paid by a patient for any particular service, it is not binding, and the actual charges for items and services may vary.
Many factors may influence the actual cost of an item or service, including insurance coverage, rates negotiated with payors, and so on. Government payors, such as Medicare and Medicaid for example, do not pay the chargemaster rates, but rather have their own set rates that hospitals are obligated to accept. Commercial insurance payments are based on contract negotiations with payors and may or may not reflect the standard charges. The cost of treatment also may be impacted by variables involved in a patient’s actual care, such as specific equipment or supplies required, the length of time spent in surgery or recovery, additional tests, or any changes in care or unexpected conditions or complications that arise. Moreover, the foregoing list of charges for services only includes charges from the Hospital. It does not reflect the charges for physicians, such as the surgeon, anesthesiologist, radiologist, pathologist, or other physician specialists or providers who may be involved in providing particular services to a patient. These charges are billed separately.
Individuals with questions about their out-of-pocket costs of service and other financial information should contact the hospital or consider contacting their insurers for further information.
Harbor Regional Health Patient Information Price List
LOCAL MARKET HOSPITALS
In order to present a meaningful comparison, Harbor Regional Health has partnered with Hospital Pricing Specialists LLC to analyze current charges, based off CMS adjudicated claims through 6/30/23. Harbor Regional Health's charges are displayed and compared with the local market charge, consisting of the following hospitals:
Mason General Hospital
Shelton
WA
MultiCare Capital Medical Center
Olympia
WA
Multicare Tacoma General Hospital
Tacoma
WA
Providence Centralia Hospital
Centralia
WA
Providence Saint Peter Hospital
Olympia
WA
Summit Pacific Medical Center
Elma
WA
Harbor Regional Health Patient Information Price List
CMS SHOPPABLE SERVICE
CMS SHOPPABLE SERVICE
Description
Variance
Psychotherapy treatment by physician face-to-face with patient (45 minutes) [HCPCS 90834]
Psychotherapy treatment by physician face-to-face with patient (45 minutes) [HCPCS 90834]
43% lower than market
Psychotherapy treatment by physician face-to-face with patient (60 minutes) [HCPCS 90837]
Psychotherapy treatment by physician face-to-face with patient (60 minutes) [HCPCS 90837]
80% lower than market
Psychotherapy treatment for multiple patients in one group session [HCPCS 90853]
Psychotherapy treatment for multiple patients in one group session [HCPCS 90853]
41% lower than market
Spinal canal injection of substance into lower back or sacrum with imaging guidance [HCPCS 62323]
Spinal canal injection of substance into lower back or sacrum with imaging guidance [HCPCS 62323]
12% lower than market
Spinal x-ray of lower and sacral spine (minimum of 4 views) [HCPCS 72110]
Spinal x-ray of lower and sacral spine (minimum of 4 views) [HCPCS 72110]
A radiologic exam is done of the lumbosacral spine. Frontal, posteroanterior, and lateral views are the most common projections taken. X-ray uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures.
4% lower than market
Abdominal and pelvic CT scan with contrast for injury, foreign bodies, or tumors [HCPCS 74177]
Abdominal and pelvic CT scan with contrast for injury, foreign bodies, or tumors [HCPCS 74177]
Computerized tomography, also referred to as a CT scan, uses special x-ray equipment and computer technology to produce multiple cross-sectional images of the abdomen and pelvis. The patient is positioned on the CT examination table. An initial pass is made through the CT scanner to determine the starting position of the scans. The CT scan is then performed. As the table moves slowly through the scanner, numerous x-ray beams and electronic x-ray detectors rotate around the abdomen and pelvis. The amount of radiation being absorbed is measured. As the beams and detectors rotate around the body, the table is moved through the scanner. A computer program processes the data which is then displayed on the monitor as two-dimensional cross-sectional images of the abdomen or pelvis. The physician reviews the data and images as they are obtained and may request additional sections to provide more detail on areas of interest.
41% higher than market
Abdominal ultrasound (complete) [HCPCS 76700]
Abdominal ultrasound (complete) [HCPCS 76700]
A real time abdominal ultrasound is performed with image documentation. The patient is placed supine. Acoustic coupling gel is applied to the skin of the abdomen. The transducer is pressed firmly against the skin and swept back and forth over the abdomen and images obtained. The ultrasonic wave pulses directed at the abdomen are imaged by recording the ultrasound echoes. Any abnormalities are evaluated to identify characteristics that might provide a definitive diagnosis. The physician reviews the ultrasound images of the abdomen and provides a written interpretation.
62% higher than market
Total Knee or Hip Replacement
Total Knee or Hip Replacement
22% higher than market
Anesthetic agent and/or steroid injection into lower or sacral spine nerve root with imaging guidance (single level) [HCPCS 64483]
Anesthetic agent and/or steroid injection into lower or sacral spine nerve root with imaging guidance (single level) [HCPCS 64483]
2% lower than market
Uterus or Ovary Surgery Not Related to Cancer without complications
Uterus or Ovary Surgery Not Related to Cancer without complications
9% higher than market
Cataract removal involving removal of the front part of the capsule and the central part of the lens with lens prosthesis insertion [HCPCS 66984]
Cataract removal involving removal of the front part of the capsule and the central part of the lens with lens prosthesis insertion [HCPCS 66984]
30% lower than market
Catheter insertion into left heart with injection, imaging interpretation, and supervision [HCPCS 93452]
Catheter insertion into left heart with injection, imaging interpretation, and supervision [HCPCS 93452]
8% lower than market
Colon (large bowel) examination and biopsy with endoscope [HCPCS 45380]
Colon (large bowel) examination and biopsy with endoscope [HCPCS 45380]
A flexible colonoscopy is performed with single or multiple biopsies. The colonoscope is inserted into the rectum and advanced through the colon to the cecum or a point within the terminal ileum, using air insufflation to separate the mucosal folds for better visualization. Mucosal surfaces of the colon are inspected and any abnormalities are noted. The endoscope is then withdrawn and mucosal surfaces are again inspected for ulcerations, varices, bleeding sites, lesions, strictures, or other abnormalities. Any suspect site(s) to be biopsied is identified and biopsy forceps are placed through the biopsy channel in the endoscope. The forceps are opened, the tissue is spiked, and the forceps are closed. The biopsied tissue is then removed through the endoscope. One or more tissue samples may be obtained and are sent for separately reportable laboratory analysis.
79% higher than market
Colon (large bowel) examination and polyps or tumors removal by snare technique with endoscope [HCPCS 45385]
Colon (large bowel) examination and polyps or tumors removal by snare technique with endoscope [HCPCS 45385]
A flexible colonoscopy is performed with removal of tumors, polyps, or other lesions by hot biopsy forceps or snare technique. The colonoscope is inserted into the rectum and advanced through the colon to the cecum or a point within the terminal ileum, using air insufflation to separate the mucosal folds for better visualization. Mucosal surfaces of the colon are inspected and any abnormalities are noted. The tumor, polyp, or other lesion is identified. Hot biopsy method uses insulated monopolar forceps to remove and electrocoagulate (cauterize) tissue simultaneously. Hot biopsy forceps are used primarily for removal of small polyps and treatment of vascular ectasias. A wire snare loop is placed around the lesion. The loop is heated to shave off and cauterize the lesion. Lesions may be removed en bloc with one placement of the snare or in a piecemeal fashion which requires multiple applications of the snare. The endoscope is withdrawn and mucosal surfaces are again inspected for ulcerations, bleeding sites, lesions, strictures, or other abnormalities.
84% higher than market
Colon (large bowel) examination with endoscope for diagnosis (high risk) [HCPCS 45378]
Colon (large bowel) examination with endoscope for diagnosis (high risk) [HCPCS 45378]
A flexible colonoscopy is performed with or without collection of specimens by brushing or washing. The colonoscope is inserted into the rectum and advanced through the colon to the cecum or a point within the terminal ileum, using air insufflation to separate the mucosal folds for better visualization. Mucosal surfaces of the colon are inspected and any abnormalities are noted. The endoscope is then withdrawn as mucosal surfaces are again inspected for ulcerations, varices, bleeding sites, lesions, strictures, or other abnormalities. Cytology (cell) samples may be obtained using a brush introduced through the endoscope. Alternatively, sterile water may be introduced to wash the mucosal lining and the fluid aspirated to obtain cell samples. Cytology samples are sent for separately reportable laboratory analysis.
59% higher than market
Esophagus, stomach, and/or upper small bowel examination and biopsy with endoscope [HCPCS 43239]
Esophagus, stomach, and/or upper small bowel examination and biopsy with endoscope [HCPCS 43239]
An upper gastrointestinal (UGI) endoscopic examination, also referred to as an esophagogastroduodenoscopy (EGD), is performed on the esophagus, stomach, duodenum and/or jejunum with biopsy(s). The mouth and throat are numbed using an anesthetic spray. A hollow mouthpiece is placed in the mouth. The flexible fiberoptic endoscope is then inserted and advanced as it is swallowed by the patient. Once the endoscope has been advanced beyond the cricopharyngeal region, it is guided using direct visualization. The esophagus is inspected and any abnormalities are noted. The endoscope is then advanced beyond the gastroesophageal junction into the stomach and the stomach is insufflated with air. The cardia, fundus, greater and lesser curvature, and antrum are inspected and any abnormalities are noted. The tip of the endoscope is then advanced through the pylorus and into the duodenum and/or jejunum where mucosal surfaces are inspected for any abnormalities. Single or multiple samples of suspect tissue are taken through the scope. The endoscope is withdrawn and mucosal surfaces are again inspected for ulcerations, varices, bleeding sites, lesions, strictures, or other abnormalities.
75% higher than market
Esophagus, stomach, and/or upper small bowel examination with endoscope for diagnosis [HCPCS 43235]
Esophagus, stomach, and/or upper small bowel examination with endoscope for diagnosis [HCPCS 43235]
A diagnostic upper gastrointestinal (UGI) endoscopic examination is performed of the esophagus, stomach, duodenum and/or jejunum with or without collection of specimens by brushing or washing. This procedure may also be referred to as an esophagogastroduodenoscopy (EGD). The mouth and throat are numbed using an anesthetic spray. A hollow mouthpiece is placed in the mouth. The flexible fiberoptic endoscope is then inserted and advanced as it is swallowed by the patient. Once the endoscope has been advanced beyond the cricopharyngeal region, it is guided using direct visualization. The esophagus is inspected and any abnormalities are noted. The endoscope is then advanced beyond the gastroesophageal junction into the stomach and the stomach is insufflated with air. The cardia, fundus, greater and lesser curvature, and antrum of the stomach are inspected and any abnormalities are noted. The tip of the endoscope is then advanced through the pylorus and into the duodenum and/or jejunum. Mucosal surfaces of the duodenum and/or jejunum are inspected and any abnormalities are noted. The endoscope is then withdrawn and mucosal surfaces are again inspected for ulcerations, varices, bleeding sites, lesions, strictures, or other abnormalities. Cytology samples may be obtained by cell brushing or washing.
5% higher than market
Gallbladder removal with an endoscope [HCPCS 47562]
Gallbladder removal with an endoscope [HCPCS 47562]
The gallbladder is removed by laparoscopic technique. A small portal incision is made at the navel and a trocar is inserted. The scope and video camera are then inserted at this site. The abdomen is inflated with carbon dioxide. Two to three additional abdominal portal incisions are made and trocars are inserted for placing surgical instruments. The gallbladder is identified. If the gallbladder is distended, a needle may be used to drain bile from the gallbladder. Grasper clamps are applied. The Hartmann's pouch is identified and retracted, exposing the triangle of Calot. The cystic artery and cystic duct are identified. The cystic duct is dissected free and transected. The cystic artery is dissected free, ligated, and doubly divided. Electrocautery is used to dissect the gallbladder off the liver bed. The gallbladder is placed in an extraction sac and removed from the abdomen through one of the small incisions.
53% higher than market
Groin hernia repair for patient 5 years of age or older (herniated tissue that is not trapped) [HCPCS 49505]
Groin hernia repair for patient 5 years of age or older (herniated tissue that is not trapped) [HCPCS 49505]
An initial inguinal hernia repair is performed on a patient who is five years or older. An inguinal hernia is a condition where structures protrude through a weakness in the abdominal wall in the groin area. Incarcerated hernia tissue cannot be pushed back into its normal position. Strangulated hernias are those in which circulation is compromised. An incision is made over the internal ring. The skin, fat, and subcutaneous fascia are incised down to the aponeurosis of the external oblique muscle. The external ring is identified and the external oblique aponeurosis is slit. The internal ring is opened and the inguinal canal is exposed. In males, the spermatic cord and its covering are mobilized and the covering is removed. The hernia sac is dissected free into the retroperitoneum, opened, and inspected for the presence of bowel or bladder wall. Any bowel or bladder content is reduced (pushed back into the abdominal cavity) and the hernia sac is transected and inverted into the abdominal cavity. A mesh plug may be placed to reinforce the repair. In women, the sac is inspected for the ovary. If the ovary is present, it is returned to the abdomen. The sac is then resected together with the round ligament. The internal ring is closed and the posterior wall of the inguinal canal is repaired.
64% higher than market
Head or brain CT scan without contrast to examine injury, foreign bodies, or tumors [HCPCS 70450]
Head or brain CT scan without contrast to examine injury, foreign bodies, or tumors [HCPCS 70450]
Computerized tomography, also referred to as a CT scan, uses special x-ray equipment and computer technology to produce multiple cross-sectional images of the region being studied. In this study, CT scan of the head or brain is performed. The patient is positioned on the CT examination table. An initial pass is made through the CT scanner to determine the starting position of the scans after which the CT scan is performed. As the table moves slowly through the scanner, numerous x-ray beams and electronic x-ray detectors rotate around the body region being examined. The amount of radiation being absorbed is measured. As the beams and detectors rotate around the body, the table is moved through the scanner. A computer program processes the data and renders the data in two-dimensional cross-sectional images of the body region being examined. This data is displayed on a monitor. The physician reviews the data as it is being obtained and may request additional sections to provide more detail of areas of interest.
38% higher than market
Imaging of brain by MRI without contrast, followed by contrast [HCPCS 70553]
Imaging of brain by MRI without contrast, followed by contrast [HCPCS 70553]
Magnetic resonance imaging is done on the brain. MRI is a noninvasive, non-radiating imaging technique that uses the magnetic properties of hydrogen atoms in the body. The patient is placed on a motorized table within a large MRI tunnel scanner that contains the magnet. The powerful magnetic field forces the hydrogen atoms to line up. Radiowaves are then transmitted within the strong magnetic field. Protons in the nuclei of different types of tissues emit a specific radiofrequency signal that bounces back to the computer, which processes the signals and converts the data into tomographic, 3D images with very high resolution. MRI of the brain provides reliable information for diagnosing the presence, location, and extent of tumors, cysts, or other masses; swelling and infection; vascular disorders or malformations, such as aneurysms and intracranial hemorrhage; disease of the pituitary gland; stroke; developmental and structural anomalies of the brain; hydrocephalus; and chronic conditions and diseases affecting the central nervous system such as headaches and multiple sclerosis.
26% lower than market
Imaging of leg joint by MRI without contrast [HCPCS 73721]
Imaging of leg joint by MRI without contrast [HCPCS 73721]
Magnetic resonance imaging is done on a joint of the upper or lower leg. Magnetic resonance is a noninvasive, non-radiating imaging technique that uses the magnetic properties of hydrogen atoms in the body. The patient is placed on a motorized table within a large MRI tunnel scanner that contains the magnet. The powerful magnetic field forces the hydrogen atoms to line up. Radiowaves are then transmitted within the strong magnetic field. Protons in the nuclei of different types of tissues emit a specific radiofrequency signal that bounces back to the computer, which processes the signals and converts the data into tomographic, 3D images with very high resolution. The patient is placed on a motorized table within a large MRI tunnel scanner that contains the magnet. Small coils that help transmit and receive the radiowaves may be placed around the joint. MRI scans on joints of the lower extremity are often done for injury, trauma, unexplained pain, redness, or swelling, and freezing of a joint with loss of motion. MRI scans provide clear images of areas that may be difficult to see on CT. The physician reviews the images to look for information that may correlate to the patient's signs or symptoms. MRI provides reliable information on the presence and extent of tumors, masses, or lesions within the joint; infection, inflammation, and swelling of soft tissue; muscle atrophy and other anomalous muscular development; and joint effusion and vascular necrosis.
37% lower than market
Imaging of lower spinal canal by MRI without contrast [HCPCS 72148]
Imaging of lower spinal canal by MRI without contrast [HCPCS 72148]
Magnetic resonance imaging (MRI) is done on the lumbar spinal canal and contents. MRI is a noninvasive, non-radiating imaging technique that uses the magnetic properties of nuclei within hydrogen atoms of the body. The powerful magnetic field forces the hydrogen atoms to line up. Radiowaves are then transmitted within the strong magnetic field. Protons in the nuclei of different types of tissues emit a specific radiofrequency signal that bounces back to the computer, which records the images. The computer processes the signals and coverts the data into tomographic, 3D, sectional images in slices with very high resolution. The patient is placed on a motorized table within a large MRI tunnel scanner that contains the magnet. MRI scans of the spine are often done when conservative treatment of back pain is unsuccessful and more aggressive treatments are considered or following surgery. The physician reviews the images to look for specific information that may correlate to the patient's symptoms, such as abnormal spinal alignment; disease or injury of vertebral bodies; intervertebral disc herniation, degeneration, or dehydration; the size of the spinal canal to accommodate the cord and nerve roots; pinched or inflamed nerves; or any changes since surgery.
40% lower than market
Imaging of pelvis by ultrasound through vagina [HCPCS 76830]
Imaging of pelvis by ultrasound through vagina [HCPCS 76830]
A transvaginal ultrasound is performed to evaluate the non-pregnant uterus and other pelvic structures. Conditions that may be evaluated by transvaginal ultrasound include infertility, abnormal bleeding, unexplained pain, congenital anomalies of the ovaries and uterus, ovarian cysts and tumors, pelvic inflammatory disease, bladder abnormalities, and intrauterine device (IUD) location. The patient is asked to empty the bladder and then lies back with the feet in stirrups. A protective cover is placed over the transducer and acoustic coupling gel is applied. The transducer is inserted into the vagina. Images of the uterus, ovaries, and surrounding pelvic structures are obtained from different orientations of the transducer. The ultrasonic wave pulses directed at the pelvic structures are imaged by recording the ultrasound echoes. The uterus is examined and endometrial thickness is determined. The ovaries are examined and any ovarian masses are carefully evaluated. The bladder and other pelvic structures are examined and any abnormalities are noted. The physician reviews the transvaginal ultrasound images and provides a written interpretation.
65% higher than market
Knee cartilage removal with endoscope (one knee) [HCPCS 29881]
Knee cartilage removal with endoscope (one knee) [HCPCS 29881]
50% higher than market
Lab analysis of urine specimen by dipstick with microscope (automated) [HCPCS 81001]
Lab analysis of urine specimen by dipstick with microscope (automated) [HCPCS 81001]
A urinalysis is performed by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, and/or urobilinogen. Urinalysis can quickly screen for conditions that do not immediately produce symptoms such as diabetes mellitus, kidney disease, or urinary tract infection. A dip stick allows qualitative and semi-quantitative analysis using a paper or plastic stick with color strips for each agent being tested. The stick is dipped in the urine specimen and the color strips are then compared to a color chart to determine the presence or absence and/or a rough estimate of the concentration of each agent tested. Reagent tablets use an absorbent mat with a few drops of urine placed on the mat followed by a reagent tablet. A drop of distilled, deionized water is then placed on the tablet and the color change is observed. Bilirubin is a byproduct of the breakdown of red blood cells by the liver. Normally bilirubin is excreted through the bowel, but in patients with liver disease, bilirubin is filtered by the kidneys and excreted in the urine. Glucose is a sugar that is normally filtered by the glomerulus and excreted only in small quantities in the urine. Excess sugar in the urine (glycosuria) is indicative of diabetes mellitus. The peroxidase activity of erythrocytes is used to detect hemoglobin in the urine which may be indicative of hematuria, myoglobinuria, or hemoglobinuria. Ketones in the urine are the result of diabetic ketoacidosis or calorie deprivation (starvation). A leukocyte esterase test identifies the presence of white blood cells in the urine. The presence of nitrites in the urine is indicative of bacteria. The pH identifies the acid-base levels in the urine. The presence of excessive amounts of protein (proteinuria) may be indicative of nephrotic syndrome. Specific gravity measures urine density and is indicative of the kidneys' ability to concentrate and dilute urine. Following dip stick or reagent testing, the urine sample may be examined under a microscope. The urine sample is placed in a test tube and centrifuged. The sediment is resuspended. A drop of the resuspended sediment is then placed on a glass slide, cover-slipped, and examined under a microscope for crystals, casts, squamous cells, blood (white, red) cells, and bacteria.
18% lower than market
Lab analysis of urine specimen by dipstick without microscope (automated) [HCPCS 81003]
Lab analysis of urine specimen by dipstick without microscope (automated) [HCPCS 81003]
A urinalysis is performed by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, and/or urobilinogen. Urinalysis can quickly screen for conditions that do not immediately produce symptoms such as diabetes mellitus, kidney disease, or urinary tract infection. A dip stick allows qualitative and semi-quantitative analysis using a paper or plastic stick with color strips for each agent being tested. The stick is dipped in the urine specimen and the color strips are then compared to a color chart to determine the presence or absence and/or a rough estimate of the concentration of each agent tested. Reagent tablets use an absorbent mat with a few drops of urine placed on the mat followed by a reagent tablet. A drop of distilled, deionized water is then placed on the tablet and the color change is observed. Bilirubin is a byproduct of the breakdown of red blood cells by the liver. Normally bilirubin is excreted through the bowel, but in patients with liver disease, bilirubin is filtered by the kidneys and excreted in the urine. Glucose is a sugar that is normally filtered by the glomerulus and excreted only in small quantities in the urine. Excess sugar in the urine (glycosuria) is indicative of diabetes mellitus. The peroxidase activity of erythrocytes is used to detect hemoglobin in the urine which may be indicative of hematuria, myoglobinuria, or hemoglobinuria. Ketones in the urine are the result of diabetic ketoacidosis or calorie deprivation (starvation). A leukocyte esterase test identifies the presence of white blood cells in the urine. The presence of nitrites in the urine is indicative of bacteria. The pH identifies the acid-base levels in the urine. The presence of excessive amounts of protein (proteinuria) may be indicative of nephrotic syndrome. Specific gravity measures urine density and is indicative of the kidneys' ability to concentrate and dilute urine. Following dip stick or reagent testing, the urine sample may be examined under a microscope. The urine sample is placed in a test tube and centrifuged. The sediment is resuspended. A drop of the resuspended sediment is then placed on a glass slide, cover-slipped, and examined under a microscope for crystals, casts, squamous cells, blood (white, red) cells, and bacteria.
11% lower than market
Lab analysis of urine specimen by dipstick without microscope (non-automated) [HCPCS 81002]
Lab analysis of urine specimen by dipstick without microscope (non-automated) [HCPCS 81002]
A urinalysis is performed by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, and/or urobilinogen. Urinalysis can quickly screen for conditions that do not immediately produce symptoms such as diabetes mellitus, kidney disease, or urinary tract infection. A dip stick allows qualitative and semi-quantitative analysis using a paper or plastic stick with color strips for each agent being tested. The stick is dipped in the urine specimen and the color strips are then compared to a color chart to determine the presence or absence and/or a rough estimate of the concentration of each agent tested. Reagent tablets use an absorbent mat with a few drops of urine placed on the mat followed by a reagent tablet. A drop of distilled, deionized water is then placed on the tablet and the color change is observed. Bilirubin is a byproduct of the breakdown of red blood cells by the liver. Normally bilirubin is excreted through the bowel, but in patients with liver disease, bilirubin is filtered by the kidneys and excreted in the urine. Glucose is a sugar that is normally filtered by the glomerulus and excreted only in small quantities in the urine. Excess sugar in the urine (glycosuria) is indicative of diabetes mellitus. The peroxidase activity of erythrocytes is used to detect hemoglobin in the urine which may be indicative of hematuria, myoglobinuria, or hemoglobinuria. Ketones in the urine are the result of diabetic ketoacidosis or calorie deprivation (starvation). A leukocyte esterase test identifies the presence of white blood cells in the urine. The presence of nitrites in the urine is indicative of bacteria. The pH identifies the acid-base levels in the urine. The presence of excessive amounts of protein (proteinuria) may be indicative of nephrotic syndrome. Specific gravity measures urine density and is indicative of the kidneys' ability to concentrate and dilute urine. Following dip stick or reagent testing, the urine sample may be examined under a microscope. The urine sample is placed in a test tube and centrifuged. The sediment is resuspended. A drop of the resuspended sediment is then placed on a glass slide, cover-slipped, and examined under a microscope for crystals, casts, squamous cells, blood (white, red) cells, and bacteria.
10% lower than market
Lab analysis to evaluate kidney function via a blood test panel [HCPCS 80069]
Lab analysis to evaluate kidney function via a blood test panel [HCPCS 80069]
A renal panel is obtained for routine health screening and to monitor conditions such as diabetes, renal disease, liver disease, nutritional disorders, thyroid and parathyroid function, and interventional drug therapies. Tests in a renal panel include glucose or blood sugar; electrolytes and minerals as sodium, potassium, chloride, total calcium, and phosphorus; the waste products blood urea nitrogen (BUN) and creatinine; a protein called albumin; and bicarbonate (carbon dioxide, CO2) responsible for acid base balance. Glucose is the main source of energy for the body and is regulated by insulin. High levels may indicate diabetes or impaired kidney function. Sodium is found primarily outside cells and maintains water balance in the tissues, as well as nerve and muscle function. Potassium is primarily found inside cells and affects heart rhythm, cell metabolism, and muscle function. Chloride moves freely in and out of cells to regulate fluid levels and help maintain electrical neutrality. Calcium is needed to support metabolic processes, heart and nerve function, muscle contraction, and blood clotting. Phosphorus is essential for energy production, nerve and muscle function, and bone growth. Blood urea nitrogen (BUN) and creatinine are waste products from tissue breakdown that circulate in the blood and are filtered out by the kidneys. Albumin, a protein made by the liver, helps to nourish tissue and transport hormones, vitamins, drugs, and calcium throughout the body. Bicarbonate (HCO3) may also be referred to as carbon dioxide (CO2) maintains body pH or the acid/base balance. A specimen is obtained by separately reportable venipuncture. Serum/plasma is tested using quantitative chemiluminescent immunoassay or quantitative enzyme-linked immunosorbent assay.
62% higher than market
Lab analysis to evaluate the clotting time in plasma specimen and monitor drug effectiveness [HCPCS 85610]
Lab analysis to evaluate the clotting time in plasma specimen and monitor drug effectiveness [HCPCS 85610]
Prothrombin time (PT) measures how long it takes for blood to clot. Prothrombin, also called factor II, is one of the clotting factors made by the liver and adequate levels of vitamin K are needed for the liver to produce sufficient prothrombin. Prothrombin time is used to help identify the cause of abnormal bleeding or bruising; to check whether blood thinning medication, such as warfarin (Coumadin), is working; to check for low levels of blood clotting factors I, II, V, VII, and X; to check for low levels of vitamin K; to check liver function, to see how quickly the body is using up its clotting factors. The test is performed using electromagnetic mechanical clot detection. If prothrombin time is elevated and the patient is not on a blood thinning medication, a second prothrombin time using substitution plasma fractions, also referred to as a prothrombin time mixing study, may be performed. This is performed by mixing patient plasma with normal plasma using a 1:1 mix. The mixture is incubated and the clotting time is again measured. If the result does not correct, it may be indicative that the patient has an inhibitor, such as lupus anticoagulant. If the result does correct, the patient may have a coagulation factor deficiency.
14% lower than market
Lab analysis to identify the thyroid stimulating hormone (tsh) in blood specimen [HCPCS 84443]
Lab analysis to identify the thyroid stimulating hormone (tsh) in blood specimen [HCPCS 84443]
A blood test is performed to determine levels of thyroid stimulating hormone (TSH). TSH is produced in the pituitary and helps to regulate two other thyroid hormones, triiodothyronine (T3) and thyroxin (T4), which in turn help regulate the body's metabolic processes. TSH levels are tested to determine whether the thyroid is functioning properly. Patients with symptoms of weight gain, tiredness, dry skin, constipation, or menstrual irregularities may have an underactive thyroid (hypothyroidism). Patients with symptoms of weight loss, rapid heart rate, nervousness, diarrhea, feeling of being too hot, or menstrual irregularities may have an overactive thyroid (hypothyroidism). TSH levels are also periodically tested in individuals on thyroid medications. The test is performed by electrochemiluminescent immunoassay.
15% lower than market
Lab analysis to measure coagulation in plasma or whole blood specimen [HCPCS 85730]
Lab analysis to measure coagulation in plasma or whole blood specimen [HCPCS 85730]
This test may also be referred to as an activated PTT or aPTT. PTT may be performed to diagnose the cause of bleeding or as a screening test prior to surgery to rule-out coagulation defects. A silica and synthetic phospholipid PTT reagent is mixed with the patient plasma. The silica provides a negatively-charged particulate surface that activates the contact pathway for coagulation. Clot formation is initiated by adding calcium chloride to the mixture. Clotting time is measured photo-optically.
40% higher than market
Lab analysis to measure complete blood cell count (red cells, white blood cell, and platelets), automated test [HCPCS 85027]
Lab analysis to measure complete blood cell count (red cells, white blood cell, and platelets), automated test [HCPCS 85027]
An automated complete blood count (CBC) is performed with or without automated differential white blood cell (WBC) count. A CBC is used as a screening test to evaluate overall health and symptoms such as fatigue, bruising, bleeding, and inflammation, or to help diagnose infection. A CBC includes measurement of hemoglobin (Hgb) and hematocrit (Hct), red blood cell (RBC) count, white blood cell (WBC) count with or without differential, and platelet count. Hgb measures the amount of oxygen-carrying protein in the blood. Hct refers to the volume of red blood cells (erythrocytes) in a given volume of blood and is usually expressed as a percentage of total blood volume. RBC count is the number of red blood cells (erythrocytes) in a specific volume of blood. WBC count is the number of white blood cells (leukocytes) in a specific volume of blood. There are five types of WBCs: neutrophils, eosinophils, basophils, monocytes, and lymphocytes. If a differential is performed, each of the five types is counted separately. Platelet count is the number of platelets (thrombocytes) in the blood. Platelets are responsible for blood clotting. The CBC is performed with an automated blood cell counting instrument that can also be programmed to provide an automated WBC differential count.
16% higher than market
Lab analysis to measure complete blood cell count (red cells, white blood cell, and platelets), automated test and automated differential white blood cell count [HCPCS 85025]
Lab analysis to measure complete blood cell count (red cells, white blood cell, and platelets), automated test and automated differential white blood cell count [HCPCS 85025]
An automated complete blood count (CBC) is performed with or without automated differential white blood cell (WBC) count. A CBC is used as a screening test to evaluate overall health and symptoms such as fatigue, bruising, bleeding, and inflammation, or to help diagnose infection. A CBC includes measurement of hemoglobin (Hgb) and hematocrit (Hct), red blood cell (RBC) count, white blood cell (WBC) count with or without differential, and platelet count. Hgb measures the amount of oxygen-carrying protein in the blood. Hct refers to the volume of red blood cells (erythrocytes) in a given volume of blood and is usually expressed as a percentage of total blood volume. RBC count is the number of red blood cells (erythrocytes) in a specific volume of blood. WBC count is the number of white blood cells (leukocytes) in a specific volume of blood. There are five types of WBCs: neutrophils, eosinophils, basophils, monocytes, and lymphocytes. If a differential is performed, each of the five types is counted separately. Platelet count is the number of platelets (thrombocytes) in the blood. Platelets are responsible for blood clotting. The CBC is performed with an automated blood cell counting instrument that can also be programmed to provide an automated WBC differential count.
6% lower than market
Lab analysis to measure the amount of albumin, total and direct bilirubin, alkaline phosphatase, total protein, alanine amino transferase, and asparate amino transferase in blood specimen to evaluate liver function [HCPCS 800
Lab analysis to measure the amount of albumin, total and direct bilirubin, alkaline phosphatase, total protein, alanine amino transferase, and asparate amino transferase in blood specimen to evaluate liver function [HCPCS 800
A hepatic function panel is obtained to diagnose acute and chronic liver disease, inflammation, or scarring and to monitor hepatic function while taking certain medications. Tests in a hepatic function panel should include albumin (ALB), total and direct bilirubin, alkaline phosphatase (ALP), total protein (TP), alanine aminotransferase (ALT, SGPT), and aspartate aminotransferase (AST, SGOT). Albumin (ALB) is a protein made by the liver that helps to nourish tissue and transport hormones, vitamins, drugs, and calcium throughout the body. Bilirubin, a waste product from the breakdown of red blood cells, is removed by the liver in a conjugated state. Bilirubin is measured as total (all the bilirubin circulating in the blood) and direct (the conjugated amount only) to determine how well the liver is performing. Alkaline phosphatase (ALP) is an enzyme produced by the liver and other organs of the body. In the liver, cells along the bile duct produce ALP. Blockage of these ducts can cause elevated levels of ALP, whereas cirrhosis, cancer, and toxic drugs will decrease ALP levels. Circulating blood proteins include albumin (60% of total) and globulins (40% of total). By measuring total protein (TP) and albumin (ALB), the albumin/globulin (A/G) ratio can be determined and monitored. TP may decrease with malnutrition, congestive heart failure, hepatic disease, and renal disease and increase with inflammation and dehydration. Alanine aminotransferase (ALT, SGPT) is an enzyme produced primarily in the liver and kidneys. In healthy individuals ALT is normally low. ALT is released when the liver is damaged, especially with exposure to toxic substances such as drugs and alcohol. Aspartate aminotransferase (AST, SGOT) is an enzyme produced by the liver, heart, kidneys, and muscles. In healthy individuals AST is normally low. An AST/ALT ratio is often performed to determine if elevated levels are due to liver injury or damage to the heart or skeletal muscles. A specimen is obtained by separately reportable venipuncture. Serum/plasma is tested using quantitative enzymatic method or quantitative spectrophotometry.
29% higher than market
Lab analysis to measure the amount of free PSA (prostate specific antigen) in serum specimen [HCPCS 84154]
Lab analysis to measure the amount of free PSA (prostate specific antigen) in serum specimen [HCPCS 84154]
Prostate specific antigen (PSA) is measured. PSA is a protein produced by normal prostate cells found in serum and exists in both free form and complexed with other proteins. In 84154, free PSA is measured, often in conjunction with total PSA, to provide an indirect measurement of complexed PSA.
208% higher than market
Lab analysis to measure the amount of lipids (cholesterol and triglycerides) in blood specimen [HCPCS 80061]
Lab analysis to measure the amount of lipids (cholesterol and triglycerides) in blood specimen [HCPCS 80061]
"A lipid panel is obtained to assess the risk for cardiovascular disease and to monitor appropriate treatment. Lipids are comprised of cholesterol, protein, and triglycerides. They are stored in cells and circulate in the blood. Lipids are important for cell health and as an energy source. A lipid panel should include a measurement of triglycerides and total serum cholesterol and then calculate to find the measurement of high density lipoprotein (HDL-C), low density lipoprotein (LDL-C) and very low density lipoprotein (VLDL-C). HDL contains the highest ratio of cholesterol and is often referred to as ""good cholesterol"" because it is capable of transporting excess cholesterol in the blood to the liver for removal. LDL contains the highest ratio of protein and is considered ""bad cholesterol"" because it transports and deposits cholesterol in the walls of blood vessels. VLDL contains the highest ratio of triglycerides and high levels are also considered ""bad"" because it converts to LDL after depositing triglyceride molecules in the walls of blood vessels. A blood sample is obtained by separately reportable venipuncture or finger stick. Serum/plasma is tested using quantitative enzymatic method."
30% lower than market
Lab analysis to measure the amount of total calcium, carbon dioxide (bicarbonate), chloride, creatinine, glucose, potassium, sodium, and urea nitrogen (BUN) in blood specimen [HCPCS 80048]
Lab analysis to measure the amount of total calcium, carbon dioxide (bicarbonate), chloride, creatinine, glucose, potassium, sodium, and urea nitrogen (BUN) in blood specimen [HCPCS 80048]
A basic metabolic blood panel is obtained that includes ionized calcium levels along with carbon dioxide (bicarbonate) (CO2), chloride, creatinine, glucose, potassium, sodium, and urea nitrogen (BUN). A basic metabolic panel with measurement of ionized calcium may be used to screen for or monitor overall metabolic function or identify imbalances. Ionized or free calcium flows freely in the blood, is not attached to any proteins, and represents the amount of calcium available to support metabolic processes such as heart function, muscle contraction, nerve function, and blood clotting. Total carbon dioxide (bicarbonate) (CO2) level is composed of CO2, bicarbonate (HCO3-), and carbonic acid (H2CO3) with the primary constituent being bicarbonate, a negatively charged electrolyte that works in conjunction with other electrolytes, such as potassium, sodium, and chloride, to maintain proper acid-base balance and electrical neutrality at the cellular level. Chloride is also a negatively charged electrolyte that helps regulate body fluid and maintain proper acid-base balance. Creatinine is a waste product excreted by the kidneys that is produced in the muscles while breaking down creatine, a compound used by the muscles to create energy. Blood levels of creatinine provide a good measurement of renal function. Glucose is a simple sugar and the main source of energy for the body, regulated by insulin. When more glucose is available than is required, it is stored in the liver as glycogen or stored in adipose tissue as fat. Glucose measurement determines whether the glucose/insulin metabolic process is functioning properly. Both potassium and sodium are positively charged electrolytes that work in conjunction with other electrolytes to regulate body fluid, stimulate muscle contraction, and maintain proper acid-base balance and both are essential for maintaining normal metabolic processes. Urea is a waste product produced in the liver by the breakdown of protein from a sequence of chemical reactions referred to as the urea or Krebs-Henseleit cycle. Urea is taken up by the kidneys and excreted in the urine. Blood urea nitrogen, BUN, is a measure of renal function, and helps monitor renal disease and the effectiveness of dialysis.
30% higher than market
Lab analysis to measure the amount of total PSA (prostate specific antigen) in serum specimen [HCPCS 84153]
Lab analysis to measure the amount of total PSA (prostate specific antigen) in serum specimen [HCPCS 84153]
Prostate specific antigen (PSA) is measured. PSA is a protein produced by normal prostate cells found in serum and exists in both free form and complexed with other proteins. Total PSA is measured ad the total amount of both free and complexed forms. Total PSA levels are higher in men with benign prostatic hyperplasia (BPH), acute bacterial prostatitis, or prostate cancer. Total PSA is used to screen for prostate cancer and evaluate the response to treatment in those with prostate cancer, but cannot be used by itself to definitively diagnose prostate cancer.
18% lower than market
Lab analysis via blood test to measure a comprehensive group of blood chemicals [HCPCS 80053]
Lab analysis via blood test to measure a comprehensive group of blood chemicals [HCPCS 80053]
A comprehensive metabolic panel is obtained that includes albumin, bilirubin, total calcium, carbon dioxide, chloride, creatinine, glucose, alkaline phosphatase, potassium, total protein, sodium, alanine amino transferase (ALT) (SGPT), aspartate amino transferase (AST) (SGOT), and urea nitrogen (BUN). This test is used to evaluate electrolytes and fluid balance as well as liver and kidney function. It is also used to help rule out conditions such as diabetes. Tests related to electrolytes and fluid balance include: carbon dioxide, chloride, potassium, and sodium. Tests specific to liver function include: albumin, bilirubin, alkaline phosphatase, ALT, AST, and total protein. Tests specific to kidney function include: BUN and creatinine. Calcium is needed to support metabolic processes such as heart function, muscle contraction, nerve function, and blood clotting. Glucose is the main source of energy for the body and is regulated by insulin. Glucose measurement determines whether the glucose/insulin metabolic process is functioning properly.
Approximately equal to market
Mammography of both breasts (screening exam) [HCPCS 77067]
Mammography of both breasts (screening exam) [HCPCS 77067]
Bilateral screening mammography is done with computer-aided lesion detection (CAD), when performed. Mammography is the radiographic imaging of the breast using low-dose ionizing radiation. The x-rays used in mammography have a longer wavelength than those typically used for bone imaging. A screening mammogram is done on asymptomatic women for early breast cancer detection when there are no known palpable masses. This is done on both breasts with two views taken on each side. The breast is compressed between planes on a machine dedicated strictly to mammography. This evens out the dense tissue and holds the breast still for a better quality image. Computer-aided detection uses algorithm analysis of the image data obtained from the mammographic films, with or without digitization of the radiographic images. The mammographic picture of the breast is used by scanning the x-ray film with a laser beam, usually converting the scanned image of the analog film into digital data for the computer first, then employing a methodical, step-by-step pattern of analyzing the data on video display for unusual or suspicious areas.
3% lower than market
Mammography of both breasts for diagnosis [HCPCS 77066]
Mammography of both breasts for diagnosis [HCPCS 77066]
These codes report diagnostic mammography of one breast or both breasts with computer-aided lesion detection (CAD), when performed. Mammography is the radiographic imaging of the breast using low-dose ionizing radiation. The x-rays used in mammography have a longer wavelength that those typically used for bone imaging. The test is done to detect tumors or cysts in women who have symptoms of breast disease or a palpable mass. The breast is compressed between planes on a machine dedicated strictly to mammography. This evens out the dense tissue and holds the breast still for a better quality image. Computer-aided detection uses algorithm analysis of the image data obtained from the mammographic films, with or without digitization of the radiographic images. The mammographic picture of the breast is used by scanning the x-ray film with a laser beam, usually converting the scanned image of the analog film into digital data for the computer first, then employing a methodical, step-by-step pattern of analyzing the data on video display for unusual or suspicious areas.
15% lower than market
Mammography of one breast for diagnosis [HCPCS 77065]
Mammography of one breast for diagnosis [HCPCS 77065]
These codes report diagnostic mammography of one breast or both breasts with computer-aided lesion detection (CAD), when performed. Mammography is the radiographic imaging of the breast using low-dose ionizing radiation. The x-rays used in mammography have a longer wavelength that those typically used for bone imaging. The test is done to detect tumors or cysts in women who have symptoms of breast disease or a palpable mass. The breast is compressed between planes on a machine dedicated strictly to mammography. This evens out the dense tissue and holds the breast still for a better quality image. Computer-aided detection uses algorithm analysis of the image data obtained from the mammographic films, with or without digitization of the radiographic images. The mammographic picture of the breast is used by scanning the x-ray film with a laser beam, usually converting the scanned image of the analog film into digital data for the computer first, then employing a methodical, step-by-step pattern of analyzing the data on video display for unusual or suspicious areas.
38% lower than market
Pelvis CT scan with contrast to examine injury, foreign bodies, or tumors [HCPCS 72193]
Pelvis CT scan with contrast to examine injury, foreign bodies, or tumors [HCPCS 72193]
Diagnostic computed tomography (CT) is done on the pelvis to provide detailed visualization of the organs and structures within or near the pelvis, such as kidneys, bladder, prostate, uterus, cervix, vagina, lymph nodes, and pelvic bones. CT uses multiple, narrow x-ray beams aimed around a single rotational axis, taking a series of 2D images of the target structure from multiple angles. Contrast material is used to enhance the images. Computer software processes the data and produces several images of thin, cross-sectional 2D slices of the targeted organ or area. Three-dimensional models of organs within the pelvis can be created by stacking multiple, individual 2D slices together. The patient is placed inside the CT scanner on the table and images are obtained of the pelvis area. The physician reviews the images to gather information for specified purposes such as diagnosing or monitoring cancer, evaluating the pelvic bones for fractures or other injury following trauma, locating abscesses or masses found during physical exam, finding the cause of pelvic pain, providing more detailed information before surgery, and evaluating the patient after surgery.
42% higher than market
Physical therapy exercise to develop strength, endurance, range of motion, and flexibility (each 15 minutes) [HCPCS 97110]
Physical therapy exercise to develop strength, endurance, range of motion, and flexibility (each 15 minutes) [HCPCS 97110]
Therapeutic exercise is the application of careful, graduated force to the body to increase strength, endurance, range of motion, and flexibility. Increased muscle strength is achieved by the deliberate overloading of a targeted muscle or muscle group and improved endurance is achieved by raising the intensity of the strengthening exercise to the targeted area(s) over a prolonged period of time. To maintain range of motion (ROM) and flexibility requires the careful movement and stretching of contractile and non-contractile tissue that may tighten with injury or neurological disease, causing weakness and/or spasticity. Therapeutic exercise can increase blood flow to the targeted area, reduce pain and inflammation, reduce the risk of blood clots from venous stasis, decrease muscle atrophy and improve coordination and motor control. Therapeutic exercise may be prescribed following acute illness or injury and for chronic conditions that affect physical activity or function.
20% lower than market
Psychotherapy treatment by physician face-to-face with patient (30 minutes) [HCPCS 90832]
Psychotherapy treatment by physician face-to-face with patient (30 minutes) [HCPCS 90832]
41% lower than market
Harbor Regional Health Patient Information Price List
INPATIENT ROOM AND BOARD DAILY CHARGES
INPATIENT ROOM AND BOARD DAILY CHARGES
Description
Variance
Semi-Private Room
Semi-Private Room
36% lower than market
Coronary Care Unit
Coronary Care Unit
45% lower than market
Harbor Regional Health Patient Information Price List
OUTPATIENT EMERGENCY DEPARTMENT
OUTPATIENT EMERGENCY DEPARTMENT
Description
Variance
Critical care delivery to critically ill or injured patient (each additional 30 minutes) [HCPCS 99292]
Critical care delivery to critically ill or injured patient (each additional 30 minutes) [HCPCS 99292]
Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes
20% lower than market
Critical care delivery to critically ill or injured patient (first 30-74 minutes) [HCPCS 99291]
Critical care delivery to critically ill or injured patient (first 30-74 minutes) [HCPCS 99291]
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes
25% lower than market
Emergency department visit for minor problem [HCPCS 99281]
Emergency department visit for minor problem [HCPCS 99281]
Emergency department visit for the evaluation and management of a patient, which requires these 3 key components: A problem focused history; A problem focused examination; and Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor.
17% lower than market
Emergency department visit for problem of high severity [HCPCS 99284]
Emergency department visit for problem of high severity [HCPCS 99284]
Emergency department visit for the evaluation and management of a patient, which requires these 3 key components: A detailed history; A detailed examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of high severity, and require urgent evaluation by the physician or other qualified health care professionals but do not pose an immediate significant threat to life or physiologic function.
6% lower than market
Emergency department visit for problem of low to moderate severity [HCPCS 99282]
Emergency department visit for problem of low to moderate severity [HCPCS 99282]
Emergency department visit for the evaluation and management of a patient, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; and Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity.
7% higher than market
Emergency department visit for problem of moderate severity [HCPCS 99283]
Emergency department visit for problem of moderate severity [HCPCS 99283]
Emergency department visit for the evaluation and management of a patient, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate severity.
30% lower than market
Emergency department visit for problem with significant threat to life [HCPCS 99285]
Emergency department visit for problem with significant threat to life [HCPCS 99285]
Emergency department visit for the evaluation and management of a patient, which requires these 3 key components within the constraints imposed by the urgency of the patient's clinical condition and/or mental status: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of high severity and pose an immediate significant threat to life or physiologic function.
2% lower than market
Harbor Regional Health Patient Information Price List
OUTPATIENT LABORATORY AND PATHOLOGY
OUTPATIENT LABORATORY AND PATHOLOGY
Description
Variance
Drug screening read by chemistry analyzers [HCPCS 80307]
Drug screening read by chemistry analyzers [HCPCS 80307]
A laboratory test is performed to detect the presence or absence of drugs classes in a patient’s system during a specific encounter. Presumptive screening is commonly done first, followed by test(s) for definitive drug identification as presumptive testing will not provide qualitative identification of individual drugs, nor quantitative levels present. A sample of blood or urine is obtained by separately reported procedure. Methods used include immunoassays, chromatography, and mass spectrometry.
28% higher than market
Drug test def 1-7 classes [HCPCS G0480]
Drug test def 1-7 classes [HCPCS G0480]
26% higher than market
Lab analysis by immunoassay (ELISA) to identify cryptosporidium (parasite) [HCPCS 87328]
Lab analysis by immunoassay (ELISA) to identify cryptosporidium (parasite) [HCPCS 87328]
11% higher than market
Lab analysis by immunoassay (ELISA) to identify Hepatitis B surface antigen [HCPCS 87340]
Lab analysis by immunoassay (ELISA) to identify Hepatitis B surface antigen [HCPCS 87340]
A laboratory test is performed to detect Hepatitis B surface antigen (HBsAg) or Hepatitis Be antigen (HBeAg) in serum/plasma by any immunoassay technique such as enzyme immunoassay (EIA), enzyme-linked immunosorbent assay (ELISA), and immunochemiluminometric assay (IMCA). The Hepatitis B surface antigen (HBsAg) neutralization test (87341) is used to confirm a positive HBsAg test. The Hepatitis Be antigen (HBeAg) test is used to monitor an active HBV infection and response to therapy. The presence of HBeAg in a sample indicates active HBV replication. Viral infectivity is based on both HBeAg and HBsAg activity. Hepatitis B is a virus that infects the liver. An individual with chronic HBV infection has an increased risk of developing cirrhosis and hepatocellular carcinoma. HBV may be transmitted in blood and body fluids between sexual partners, from mother to infant, and through contaminated objects such as needles, razors, and toothbrushes. The virus may cause fever, fatigue, abdominal pain, weight loss, nausea/vomiting, and joint pain, or it may be asymptomatic. A serum or plasma sample is obtained and placed in a fixative or sent fresh to the laboratory for processing. Both EIA and ELISA detect very small quantities of the antigen when bound to its specific antibody in a sample by adding a secondary, enzyme-labeled antibody to detect its presence. A chromogenic reaction of the enzyme produces a visible color change or fluorescence. Qualitative and semi-quantitative measures are assessed by the colorimetric reading. Immunochemiluminometric assay uses the reaction of antibodies labeled with a chemiluminescent substance to identify and quantify the bound antigen-antibody complex by light emission.
49% lower than market
Lab analysis by immunoassay (ELISA) to identify HIV-1 and HIV-2 [HCPCS 87389]
Lab analysis by immunoassay (ELISA) to identify HIV-1 and HIV-2 [HCPCS 87389]
31% lower than market
Lab analysis by immunoassay to identify Strep (streptococcus) [HCPCS 87880]
Lab analysis by immunoassay to identify Strep (streptococcus) [HCPCS 87880]
A direct optical test to detect Streptococcus Group A (Strep A) by immunoassay is a rapid, qualitative test performed using lateral flow immunoassay. Strep A causes acute upper respiratory infection with the most common symptoms being pharyngitis (sore throat) and fever. If left untreated serious complications can occur including rheumatic fever and glomerulonephritis. This type of test is a rapid, qualitative test performed using lateral flow immunoassay. A throat swab is obtained. Two reagents are added to extract Strep A antigen from the specimen. A dipstick is added to the extracted sample. If Strep A antigen is present the test line and a control line will change color indicating a positive test. Another method uses a throat swab specimen inserted into a test cassette. Antigen extraction solutions are then mixed in a separate chamber of the tube and added to the swab chamber. If Strep A is present, a test line will change color as will a second control line.
42% lower than market
Lab analysis by nucleic acid (DNA or RNA) to identify chlamydia trachomatis by amplified probe technique [HCPCS 87491]
Lab analysis by nucleic acid (DNA or RNA) to identify chlamydia trachomatis by amplified probe technique [HCPCS 87491]
Infectious agent antibody detection by nucleic acid technique (DNA or RNA) is used to identify Chlamydia trachomatis infection using direct probe, amplified probe, or quantification of the amplified probe. C. trachomatis infection is a sexually transmitted disease (STD) that often produces no symptoms, but can cause irreversible damage to the female reproductive tract, resulting in infertility. In men, symptoms include burning and itching of the urethra, but men rarely suffer reproductive damage from the infection. Some types of nucleic acid tests are rapid tests that may be performed in the physician office using a test kit. A swab is used to obtain a specimen from the cervix, male urethra, or eye. The exact methodology is dependent on the test kit used as there are several manufacturers. One test kit uses a nucleic acid hybridization method. A single stranded chemiluminescent DNA probe is used that is complementary to the ribosomal RNA of the Chlamydia organism. Lysate is used to rupture cells and release nucleic acids. The ribosomal RNA from the Chlamydia organism then combines with the labeled DNA probe to form a stable DNA:RNA hybrid. The presence of DNA:RNA hybrids is then detected using a luminometer. In an amplification technique, such as polymerase chain reaction (PCR), is used to create copies of the Chlamydia nucleic acids. Amplification is used when it is suspected that there are low levels of the targeted microorganism in the specimen that would not be detected using a direct probe. The Chlamydia nucleic acid is then detected using a variety of techniques.
39% lower than market
Lab analysis by nucleic acid (DNA or RNA) to identify clostridium difficile by amplified probe technique [HCPCS 87493]
Lab analysis by nucleic acid (DNA or RNA) to identify clostridium difficile by amplified probe technique [HCPCS 87493]
6% lower than market
Lab analysis by nucleic acid (DNA or RNA) to identify multiple types of the influenza virus (first 2 types or sub-types) [HCPCS 87502]
Lab analysis by nucleic acid (DNA or RNA) to identify multiple types of the influenza virus (first 2 types or sub-types) [HCPCS 87502]
36% lower than market
Lab analysis by nucleic acid (DNA or RNA) to identify Neisseria gonorrhoeae (gonorrhoeae bacteria) by amplified probe technique [HCPCS 87591]
Lab analysis by nucleic acid (DNA or RNA) to identify Neisseria gonorrhoeae (gonorrhoeae bacteria) by amplified probe technique [HCPCS 87591]
Neisseria gonorrhoeae (N. gonorrhoeae) causes gonorrhea, a sexually transmitted disease (STD), that is spread through direct contact and can infect the reproductive tract, mouth, throat, eyes, and anus. N. gonorrhoeae often causes no symptoms in women, but can cause irreversible damage to the reproductive tract of women which can result in infertility. In men, symptoms include burning, itching, and discharge of the urethra, but men rarely suffer reproductive damage from the infection. Some types of nucleic acid tests are rapid tests that may be performed in the physician office using a test kit. A swab is used to obtain a specimen from the cervix, male urethra, mouth, throat, or eye. An amplification technique, such as polymerase chain reaction (PCR) or transcription mediated amplification (TMA) is used to create copies of the N. gonorrhoeae nucleic acids. Amplification is used when there may be low levels of the suspected microorganism in the specimen that would not be detected using a direct probe. The N. gonorrhoeae nucleic acid is then detected using a variety of techniques.
19% lower than market
Lab analysis of any culture (except blood) to identify aerobic isolates (each isolate) [HCPCS 87077]
Lab analysis of any culture (except blood) to identify aerobic isolates (each isolate) [HCPCS 87077]
Used if further testing is required from an anaerobic bacterial tissue culture in order to verify the results.
14% lower than market
Lab analysis of any culture (except blood) to identify anaerobic bacteria [HCPCS 87075]
Lab analysis of any culture (except blood) to identify anaerobic bacteria [HCPCS 87075]
A tissue sample is collected and placed in a medium conducive to the growth of bacteria. The culture is examined for the growth of bacteria that can survive without oxygen.
45% lower than market
Lab analysis of any culture (except blood) to identify anaerobic isolates (each isolate) [HCPCS 87076]
Lab analysis of any culture (except blood) to identify anaerobic isolates (each isolate) [HCPCS 87076]
47% lower than market
Lab analysis of any culture (except urine, blood, or stool) to identify bacteria [HCPCS 87070]
Lab analysis of any culture (except urine, blood, or stool) to identify bacteria [HCPCS 87070]
A tissue sample besides blood, urine, or stool is collected and placed in a medium conducive to the growth of bacteria. The culture is examined for the growth of bacteria.
50% lower than market
Lab analysis of blood culture to identify bacteria [HCPCS 87040]
Lab analysis of blood culture to identify bacteria [HCPCS 87040]
A blood sample is drawn and placed in a medium conducive to the growth of bacteria. Any bacteria present in the blood sample will then reveal themselves.
13% lower than market
Lab analysis of complex special stain to identify parasites [HCPCS 87209]
Lab analysis of complex special stain to identify parasites [HCPCS 87209]
19% lower than market
Lab analysis of special gram or Giemsa stain to idenitfy microorganisms [HCPCS 87205]
Lab analysis of special gram or Giemsa stain to idenitfy microorganisms [HCPCS 87205]
A laboratory test is performed to identify bacteria, fungi, or cell types in pus, normally sterile body fluid(s), or aspirated material using Gram or Giemsa stain technique. Gram staining is a differential technique used to classify bacteria into gram positive (Gram +) or gram negative (Gram -) groups. Gram + bacteria have a thick layer of peptidoglycan in the cell wall which stains purple. Giemsa technique is used in cytogenetics for chromosome staining; in histopathology to detect trichomonas, some spirochetes, protozoans, malaria, and other parasites; and as a stain for peripheral blood and bone marrow to differentiate cells types such as erythrocytes, platelets, lymphocyte cytoplasm, monocyte cytoplasm, and leukocyte nuclear chromatin. A drop of suspended culture or cell material is applied in a thin layer to a slide using an inoculation hook and fixed with heat. The material is stained and the slide is examined under a microscope. The bacteria, fungi, or cells are identified, counted, and a written report of the findings is made.
23% lower than market
Lab analysis of stool culture to identify bacteria [HCPCS 87045]
Lab analysis of stool culture to identify bacteria [HCPCS 87045]
A stool sample is collected and placed in a medium conducive to the growth of bacteria. The culture is examined for the growth of Salmonella and Shigella bacteria.
47% lower than market
Lab analysis of stool culture to identify bacteria and additional pathogens [HCPCS 87046]
Lab analysis of stool culture to identify bacteria and additional pathogens [HCPCS 87046]
70% lower than market
Lab analysis of urine culture to measure the amount of bacteria [HCPCS 87086]
Lab analysis of urine culture to measure the amount of bacteria [HCPCS 87086]
"A laboratory test is performed to determine the presence or absence of bacterial colonies in urine and provide a colony count. Bacteria in urine may indicate an acute or chronic urinary tract infection (UTI) including pyelonephritis, cystitis, urethritis, or acute urethral syndrome. A urine sample is obtained by clean catch, mid-stream void or catheterization. Using a calibrated loop, the urine specimen is inoculated onto agar plates and incubated. Quantitative colony counts are determined and potential pathogens are identified. A colony count 10,000 cfu/mL is reported as ""organism present"" and may indicate an infection. Comingled flora of the urethra and mixed organisms in the colony counts are reported as ""mixed flora"" and most often represent contamination."
61% lower than market
Lab analysis of urine specimen by dipstick to detect the hormone found in women in early pregnancy [HCPCS 81025]
Lab analysis of urine specimen by dipstick to detect the hormone found in women in early pregnancy [HCPCS 81025]
Pregnancy tests detect the presence of human chorionic gonadotropin (hCG) in the urine. HCG is produced by the placenta and can be detected in urine shortly after the embryo attaches to the uterine lining. The test may be performed by collecting a urine specimen and dipping a stick treated to detect the presence of hCG in the urine. The presence of hCG is indicated by a color change in the treated section of the dipstick indicating a positive pregnancy test. If no color change occurs, the test is negative.
24% lower than market
Lab analysis to evaluate an antimicrobial drug (antibiotic, antifungal, antiviral) by microdilution or agar dilution (each multi-antimicrobial, per plate) [HCPCS 87186]
Lab analysis to evaluate an antimicrobial drug (antibiotic, antifungal, antiviral) by microdilution or agar dilution (each multi-antimicrobial, per plate) [HCPCS 87186]
A study is performed to determine the effectiveness of a specific antibiotic agent to a specific bacteria. The test is performed in an agar solution.
2% lower than market
Lab analysis to identify chemicals in kidney stone by infrared spectroscopy [HCPCS 82365]
Lab analysis to identify chemicals in kidney stone by infrared spectroscopy [HCPCS 82365]
4% higher than market
Lab analysis to identify Hepatitis B core antibodies (IgG and IgM) [HCPCS 86704]
Lab analysis to identify Hepatitis B core antibodies (IgG and IgM) [HCPCS 86704]
A blood sample is tested for hepatitis B core antibody (HBcAB). Hepatitis B is an inflammation of the liver caused by the hepatitis B virus (HBV) and has an acute and chronic phase. The core antibody is produced during and after an acute HBV infection, even in individuals who have cleared the virus without developing a chronic infection, and also during the chronic phase. In 86704, total HBcAB is tested using chemiluminescent assay. Both IgG and IgM antibodies are identified in a single test that does not differentiate between the two. Since IgM antibody is found in the initial phase of the infection and IgG in the later phase, this test is not specific to the acute or chronic phase of the infection.
1% lower than market
Lab analysis to identify Hepatitis B surface antibodies [HCPCS 86706]
Lab analysis to identify Hepatitis B surface antibodies [HCPCS 86706]
A blood sample is tested for hepatitis B surface antibody (HBsAB). Hepatitis B is an inflammation of the liver caused by the hepatitis B virus (HBV). HBsAB testing is performed to identify previous exposure to HBV without current acute or chronic infection, to determine the need for vaccination, and whether or not a previously administered vaccination has been successful. Individuals with a positive HBsAB test have been exposed to the virus but no longer carry an active form of the virus, cannot pass it on to others, and are immune from future HBV infection. HBsAB is tested using chemiluminescent assay.
38% lower than market
Lab analysis to identify Hepatitis C antibodies [HCPCS 86803]
Lab analysis to identify Hepatitis C antibodies [HCPCS 86803]
A laboratory test is performed to measure Hepatitis C virus (HCV) antibodies. Hepatitis C causes acute or chronic liver inflammation and may be transmitted via blood transfusion, needle sticks or sharing of needles in occupational situations or recreational drug use, unprotected sex, placental transfer during pregnancy, or sharing personal items such as a razor or toothbrush. The test is used to screen individuals at risk for infection with HCV. A blood sample is obtained by separately reportable venipuncture. Serum is tested using qualitative chemiluminescent immunoassay. Antibodies toward HCV may not start to elevate until 2 months after exposure, so a negative test screening should be repeated if there is a strong suspicion of HCV infection.
5% higher than market
Lab analysis to identify lactoferrin (immune system protein) in stool specimen [HCPCS 83630]
Lab analysis to identify lactoferrin (immune system protein) in stool specimen [HCPCS 83630]
19% lower than market
Lab analysis to identify total thyroxine (thyroid chemical) function in serum specimen for screening [HCPCS 84436]
Lab analysis to identify total thyroxine (thyroid chemical) function in serum specimen for screening [HCPCS 84436]
A blood sample is obtained and levels of total thyroxin (84436), thyroxine requiring elution as for testing in neonates (84437), or free thyroxine (84439) are evaluated. Thyroxine, also referred to as T4, is tested to determine whether the thyroid is functioning properly and is used to aid in the diagnosis of overactive (hyperthyroidism) or underactive (hypothyroidism) thyroid function. In 84436, total thyroxine levels are evaluated. Total thyroxine measures the total amount of both bound and unbound (free) thyroxine in the blood. All thyroxine tests use electrochemiluminescent immunoassay methodology. *
27% higher than market
Lab analysis to measure blood count (hemoglobin) [HCPCS 85018]
Lab analysis to measure blood count (hemoglobin) [HCPCS 85018]
A blood test is performed to determine hemoglobin (Hgb) which is a measurement of the amount of oxygen-carrying protein in the blood. Hgb is measured to determine the severity of anemia or polycythemia, monitor response to treatment for these conditions, or determine the need for blood transfusion. A blood sample is collected by separately reportable venipuncture or finger, heel, or ear stick. The sample may be sent to the lab or a rapid testing system may be used in the physician's office. Systems consist of a portable photometer and pipettes that contain reagent. The pipette is used to collect the blood sample from a capillary stick and the blood is automatically mixed with the reagent in the pipette. The photometer is then used to read the result which is displayed on the photometer device.
24% lower than market
Lab analysis to measure coagulation function measurement of D-dimer (quantitative) [HCPCS 85379]
Lab analysis to measure coagulation function measurement of D-dimer (quantitative) [HCPCS 85379]
D-dimer testing for fibrin degradation products is performed to help rule out the presence of a thrombus. D-dimer tests are also used to rule-out hypercoagulability. D-dimer has a negative predictive value for these conditions which means that a negative result indicates that there is not an elevated level of fibrin degradation products present in the specimen. A positive result indicates an abnormally high level of fibrin degradation products which may be indicative of a thrombus. It is used to help diagnosis deep vein thrombophlebitis, pulmonary embolus, and stroke. The test is also used to evaluate for hypercoagulability which predisposes the patient to blood clots and to help diagnose disseminated intravascular coagulation (DIC) and monitor the effectiveness of DIC treatment.
46% lower than market
Lab analysis to measure the parathormone (parathyroid hormone) level [HCPCS 83970]
Lab analysis to measure the parathormone (parathyroid hormone) level [HCPCS 83970]
A blood or tissue test is performed to measure parathormone (parathyroid hormone, parathyrin) levels. Parathyroid hormone (PTH) is produced by chief cells in the parathyroid gland. The hormone helps to regulate blood calcium levels, absorption/excretion of phosphate by the kidneys and in Vitamin D synthesis in the body. Elevated levels (hyperparathyroidism) may be caused by parathyroid gland tumors or chronic renal failure. Decreased levels (hypoparathyroidism) may result from inadvertent removal (during thyroid gland surgery), autoimmune disorders or genetic inborn errors of metabolism. A blood sample is obtained by separately reportable venipuncture. Parathyroid gland tissue is obtained by separately reportable fine needle aspirate. Serum/plasma or tissue sample are tested using quantitative electrochemiluminescent immunoassay. Plasma is tested for parathyroid hormone, CAP (Cyclase Activating Parathyroid Hormone) using immunoradiometric assay.
26% lower than market
Lab analysis to measure free thyroxine (thyroid chemical) in serum specimen [HCPCS 84439]
Lab analysis to measure free thyroxine (thyroid chemical) in serum specimen [HCPCS 84439]
A blood sample is obtained and levels of total thyroxin, thyroxine requiring elution as for testing in neonates or free thyroxine are evaluated. Thyroxine, also referred to as T4, is tested to determine whether the thyroid is functioning properly and is used to aid in the diagnosis of overactive (hyperthyroidism) or underactive (hypothyroidism) thyroid function. In free thyroxine levels are tested. Free thyroxine is the amount of active thyroxine in the blood. Free thyroxine levels are considered to be a more accurate indicator of thyroid function. All thyroxine tests use electrochemiluminescent immunoassay methodology.
Approximately equal to market
Lab analysis to measure the phosphate level [HCPCS 84100]
Lab analysis to measure the phosphate level [HCPCS 84100]
A blood or urine test is performed to measure inorganic phosphorus (phosphate) levels. Phosphate is an intracellular anion, found primarily in bone and soft tissue. It plays an important role in cellular energy (nerve and muscle function) and the building/repair of bone and teeth. Decreased levels are most often caused by malnutrition and lead to muscle and neurological dysfunction. Elevated levels may be due to kidney or parathyroid gland problems. A blood sample is obtained by separately reportable venipuncture. Serum/plasma is tested using quantitative spectrophotometry.
5% higher than market
Lab analysis to measure platelet count (automated test) [HCPCS 85049]
Lab analysis to measure platelet count (automated test) [HCPCS 85049]
53% lower than market
Lab analysis to measure the prealbumin (protein) level in urine specimen [HCPCS 84134]
Lab analysis to measure the prealbumin (protein) level in urine specimen [HCPCS 84134]
A blood test is performed to measure prealbumin levels. Prealbumin, also referred to as transthyretin (TTR) is found in serum and cerebral spinal fluid (CSF). It is responsible for transporting thyroxin and retinol binding protein carried on retinol. The test may be ordered to detect protein-calorie malnutrition in chronically or critically ill individuals. Levels may be elevated with the use of high dose corticosteroids or non-steroidal anti-inflammatory drugs (NSAIDs), adrenal gland disorders, Hodgkin's disease, and kidney failure. Decreased levels may be caused by hyperthyroidism, liver disease, severe infection, inflammatory diseases, and certain digestive disorders. A blood sample is obtained by separately reportable venipuncture. Serum/plasma is tested using immunoturbidimetric method.
53% lower than market
Lab analysis to measure the procalcitonin (hormone) level in serum or plasma specimen [HCPCS 84145]
Lab analysis to measure the procalcitonin (hormone) level in serum or plasma specimen [HCPCS 84145]
2% higher than market
Lab analysis to measure red blood cell concentration [HCPCS 85014]
Lab analysis to measure red blood cell concentration [HCPCS 85014]
A blood test is performed to determine hematocrit (Hct). Hematocrit refers to the volume of red blood cells (erythrocytes) in a given volume of blood and is usually expressed as a percentage of total blood volume. A blood sample is obtained by separately reportable venipuncture or finger, heel, or ear stick. Hct is calculated using an electronic cell counter.
22% lower than market
Lab analysis to measure the sex hormone binding globulin (protein) level in serum specimen [HCPCS 84270]
Lab analysis to measure the sex hormone binding globulin (protein) level in serum specimen [HCPCS 84270]
25% lower than market
Lab analysis to measure red blood cell sedimentation rate to detect inflammation (non-automated) [HCPCS 85651]
Lab analysis to measure red blood cell sedimentation rate to detect inflammation (non-automated) [HCPCS 85651]
Lab test for Sedimentation rate
20% lower than market
Lab analysis to measure the the alpha-fetoprotein (AFP) level in serum specimen [HCPCS 82105]
Lab analysis to measure the the alpha-fetoprotein (AFP) level in serum specimen [HCPCS 82105]
Alpha-fetoprotein (AFP) is measured in serum or amniotic fluid during pregnancy to screen for neural tube defects such as spina bifida and anencephaly, chromosomal abnormalities such as Down syndrome or Edwards syndrome, and omphalocele. AFP is a protein produced by the yolk sac of the fetus in early gestation and then later by the liver and gastrointestinal tract of the fetus. A blood sample is obtained by separately reportable venipuncture between 14 and 22 weeks gestation. The blood (serum) test screens for high and low levels of AFP. High levels are associated with neural tube defects while low levels are associated with chromosomal abnormalities.
6% higher than market
Lab analysis to measure the ammonia level [HCPCS 82140]
Lab analysis to measure the ammonia level [HCPCS 82140]
A blood test is performed to measure ammonia levels. Ammonia is a by product of protein metabolism and is normally converted to urea by the liver and excreted via the kidney. Elevated ammonia levels may result from cirrhosis or hepatitis. Symptoms of elevated ammonia levels are confusion, tremors, excessive sleepiness, or coma. Testing may be performed in disease states such as Reyes syndrome or liver failure. A blood sample is obtained by a separately reportable venipuncture or arterial access line. The specimen is then tested using colorimetry.
43% lower than market
Lab analysis to measure the total creatine kinase (cardiac enzyme) level in blood specimen [HCPCS 82550]
Lab analysis to measure the total creatine kinase (cardiac enzyme) level in blood specimen [HCPCS 82550]
Creatine kinase (CK) also known as, creatine phosphokinase (CPK), is an enzyme found in the heart, brain, skeletal muscle and certain other tissue. The subtypes are known as CK-MM found primarily in skeletal and heart muscle, CK-MB found in heart muscle and CK-BB located in the brain. CK circulating in blood rarely contains CK-BB but is largely comprised of CK-MM or CK-MB. Levels may be elevated following heart muscle damage (heart attack/myocardial infarction) and skeletal muscle injury (trauma, vigorous exercise). Statin drugs that lower cholesterol level and alcohol intake may cause elevated CK blood levels. A blood test is performed to measure total creatine kinase (CK) levels. A blood specimen is obtained by separately reportable venipuncture. Serum or plasma is tested using quantitative enzymatic methodology.
1% lower than market
Lab analysis to measure the amount of blood gases with oxygen saturation [HCPCS 82805]
Lab analysis to measure the amount of blood gases with oxygen saturation [HCPCS 82805]
48% lower than market
Lab analysis to measure the total protein level in blood specimen [HCPCS 84155]
Lab analysis to measure the total protein level in blood specimen [HCPCS 84155]
A blood test is performed to measure total protein levels. Total protein is often reported as a ratio of albumin to globulin (A/G ratio), and normal results will show albumin slightly greater than globulin. The test may be used to monitor nutritional status or diagnose kidney and liver disease. Elevated levels can indicate chronic inflammation, viral hepatitis, HIV infection, and multiple myeloma. Levels that are decreased may result from malnutrition or malabsorption syndromes such as celiac disease or inflammatory bowel disease. A blood sample is obtained by separately reportable venipuncture. Serum, plasma, or whole blood may be tested using quantitative spectrophotometry.
4% higher than market
Lab analysis to measure the amount of C-reactive protein in serum by high sensitivity assay to identify infection or inflammation [HCPCS 86141]
Lab analysis to measure the amount of C-reactive protein in serum by high sensitivity assay to identify infection or inflammation [HCPCS 86141]
Lab test for High Sensitivity C-reactive protein
28% lower than market
Lab analysis to measure the uric acid level in blood specimen [HCPCS 84550]
Lab analysis to measure the uric acid level in blood specimen [HCPCS 84550]
A blood test is performed to measure uric acid levels. Uric acid forms from the natural breakdown of body cells and the food we ingest. Uric acid is normally filtered by the kidneys and excreted in urine. Elevated blood levels may result from kidney disease, certain cancers and/or cancer therapies, hemolytic or sickle cell anemia, heart failure, cirrhosis, lead poisoning, and low levels of thyroid or parathyroid hormones. Levels may be decreased in Wilson's disease, poor dietary intake of protein, and with the use of certain drugs. A blood sample is obtained by separately reportable venipuncture. Serum/plasma is tested using quantitative spectrophotometry.
33% higher than market
Lab analysis to measure the amount of C-reactive protein in serum to identify infection or inflammation [HCPCS 86140]
Lab analysis to measure the amount of C-reactive protein in serum to identify infection or inflammation [HCPCS 86140]
A blood test is performed to measure C-reactive protein (CRP) levels. This standard test has a wide value range. CRP is an acute phase protein, synthesized by the liver and released in response to inflammation and infection. The test is not diagnostic for any specific disease or condition but can be used as a marker to monitor the body's response to treatment(s) or to evaluate the need for further testing. Elevation of CRP levels may be found during pregnancy, with the use of oral contraceptives, or hormone replacement therapy. Diseases/conditions that cause an elevation of CRP include: lymphoma, arteritis/vasculitis, osteomyelitis, inflammatory bowel disease, rheumatoid arthritis, pelvic inflammatory disease (PID), systemic lupus erythematosus (SLE), acute infections, burns, surgical procedures, and organ transplants. A blood sample is obtained by separately reportable venipuncture. Serum in neonates is tested using immunoassay. Serum/plasma in all other patients is tested using quantitative immunoturbidimetric method.
66% lower than market
Lab analysis to measure the vitamin D-3 level in serum or plasma specimen [HCPCS 82306]
Lab analysis to measure the vitamin D-3 level in serum or plasma specimen [HCPCS 82306]
Blood levels of 25-hydroxyvitamin D are used to primarily to determine whether a deficiency of Vitamin D or abnormal metabolism of calcium is the cause of bone weakness or malformation. Vitamin D is a fat soluble vitamin that is absorbed from the intestine like fat, and 25-hydroxyvitamin D levels are also evaluated in individuals with conditions or diseases that interfere with fat absorption, such as cystic fibrosis, Crohn's disease, or in patients who have undergone gastric bypass surgery. A blood sample is obtained. Levels of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 are evaluated using chemiluminescent immunoassay. The test results may be the sum of Vitamin D3 and D2 or the results may include fractions of D3 and D2 as well as the sum of these values.
37% lower than market
Lab analysis to measure the amount of free thyroid hormone, T3 in serum specimen [HCPCS 84481]
Lab analysis to measure the amount of free thyroid hormone, T3 in serum specimen [HCPCS 84481]
A blood sample is tested to determine levels of total triiodothyronine (T3), free T3, or reverse T3. T3 is a hormone made by the thyroid gland that affects almost every metabolic process including body temperature, growth, and heart rate. T3 can either be produced by the thyroid or synthesized by the body from T4. Approximately 95% of T3 is bound to proteins in the blood and is inactive. The remaining 5% is free and active. T3 tests are used to help determine whether the thyroid is functioning properly, to diagnose hyperthyroidism, and to monitor patients with known thyroid disorders. In total T3, which reflects the amount of both bound and free T3, is measured. Total and free T3 are evaluated using electrochemiluminescent immunoassay.
12% lower than market
Lab analysis to measure total testosterone (hormone) level in serum specimen [HCPCS 84403]
Lab analysis to measure total testosterone (hormone) level in serum specimen [HCPCS 84403]
A urine test is performed to measure total testosterone level. Testosterone is an androgen hormone secreted in the testes of men, ovaries of women, and the adrenal glands of both sexes. Testosterone helps promote protein synthesis and supports the growth of cells and tissue. This test is often performed in conjunction with sex hormone binding globulin. A blood sample is obtained by separately reportable venipuncture. Serum/plasma of adult males is tested using quantitative electrochemiluminescent immunoassay with the value derived from a mathematical expression using sex hormone binding globulin (SHBG). Serum/plasma of adult males may also be tested using quantitative equilibrium dialysis/high performance liquid chromatography-tandem mass spectrometry. Serum/plasma of children and adult females is tested using quantitative high performance liquid chromatography-tandem mass spectrometry/electrochemiluminescent immunoassay with the value also derived from a mathematical expression using sex hormone binding globulin (SHBG).
53% lower than market
Lab analysis to measure the amount of gammaglobulin (immune system protein) [HCPCS 82784]
Lab analysis to measure the amount of gammaglobulin (immune system protein) [HCPCS 82784]
A test is performed to measure immunoglobin levels in the blood or other body fluids, such as saliva or cerebral spinal fluid. Immunoglobins, also referred to as antibodies, are evaluated to help diagnose a variety of conditions including autoimmune diseases, allergies, or malignant neoplasms such as multiple myeloma or macroglobulinemia. In addition, immunoglobulin levels may be evaluated in patients with frequent infections to determine if there is a low level of immunoglobulin IgG. Immunoglobulins are also evaluated in patients with cancer or H. pylori infection to determine the effectiveness of treatment. There are five major types of antibodies. IgA antibodies are found in the nose, respiratory and digestive tracts, ears, eyes, and vagina. IgA protects the body surfaces from outside foreign substances. IgD is found in tissues lining the abdominal and thoracic cavity. IgE is found in the lungs, skin, and mucous membranes and reacts to substances commonly associated with allergies, such as food, pollen, dander, dust, fungus spores, etc. High levels of IgE are associated with allergies. IgG is found in all body fluids and is important in fighting bacterial and viral infections. There are four subclasses of IgG, designated as IgG1, IgG2, IgG3, and IgG4. These different subclasses protect against different types of infection. For example IgG1 is particularly effective in protecting the body from viral proteins, whereas IgG2 is more effective against certain types of bacterial infections. Individuals may have selective IgG subclass deficiencies characterized by low levels of one or two IgG subclasses with normal total IgG. IgM is found in blood and lymph and is important in fighting infection. A blood specimen is obtained by separately reportable venipuncture, a CSF sample is obtained by separately reportable spinal puncture, or saliva is collected. The methodology used to test immunoglobulin levels is dependent on the type of specimen and the immunoglobulin being tested.
Approximately equal to market
Lab analysis to measure urea nitrogen level in serum or plasma specimen to assess kidney function (quantitative) [HCPCS 84520]
Lab analysis to measure urea nitrogen level in serum or plasma specimen to assess kidney function (quantitative) [HCPCS 84520]
A blood sample is obtained to measure total (quantitative) urea nitrogen (BUN) level. Urea is a waste product produced in the liver by the breakdown of protein from a sequence of chemical reactions referred to as the urea or Krebs-Henseleit cycle. Urea then enters the bloodstream, is taken up by the kidneys and excreted in the urine. Blood BUN is measured to evaluate renal function, to monitor patients with renal disease, and to evaluate effectiveness of dialysis. BUN may also be measured in patients with acute or chronic illnesses that affect renal function. BUN is measured using spectrophotometry.
18% higher than market
Lab analysis to measure the amount of hepatitis A antibody, hepatitis B core antibody, hepatitis B surface antigen, and hepatitis C antibody in blood specimen to evaluate acute hepatitis [HCPCS 80074]
Lab analysis to measure the amount of hepatitis A antibody, hepatitis B core antibody, hepatitis B surface antigen, and hepatitis C antibody in blood specimen to evaluate acute hepatitis [HCPCS 80074]
An acute hepatitis panel is obtained to detect and diagnose acute or chronic viral liver infections. Hepatitis A virus (HAV) is highly contagious but usually causes only a mild illness. HAV is found in contaminated food and water but may also be spread person to person by close physical contact. It does not cause a chronic infection and a vaccine is available. Hepatitis B virus (HBV) is found in blood and body fluids and is the most common hepatitis virus contracted. It is a chronic infection and a vaccine is available against HBV. Hepatitis C virus is also found in blood and body fluids, and is chronic, however no vaccine is yet available to protect against this virus. Tests in an acute hepatitis panel should include Hepatitis A antibody, IgM antibody (HAAb IgM Ab), Hepatitis B core antibody, IgM antibody (HBcAb IgM Ab), Hepatitis B surface antigen (HBsAg), and Hepatitis C antibody (by CIA or Interp). Hepatitis A Virus antibody, IgM develops 2-3 weeks post exposure and remains elevated for 2-6 months. Hepatitis B Virus core antibody, IgM is produced in response to the presence of Hepatitis B core antigen. It will be elevated with acute initial infection and during flare up of disease activity in chronic infection. Hepatitis B Virus surface antigen is a protein located on the surface of HBV. Elevated levels of HBsAg may be an early sign of exposure to the virus or indicate an acute or chronic infection. When testing for Hepatitis C antibody, it is not possible to distinguish whether elevated levels are due to active acute infection or a chronic disease state unless differentiated by further testing. A specimen is obtained by separately reportable venipuncture. Serum/plasma is tested using quantitative chemiluminescent immunoassay.
17% lower than market
Lab analysis to screen for antibody to noninfectious agents [HCPCS 86255]
Lab analysis to screen for antibody to noninfectious agents [HCPCS 86255]
53% lower than market
Lab analysis to measure the amount of Hepatitis C virus [HCPCS 87522]
Lab analysis to measure the amount of Hepatitis C virus [HCPCS 87522]
The hepatitis C virus (HCV) causes inflammation of the liver. Individuals infected with HCV often develop chronic hepatitis C which can lead to cirrhosis and liver cancer. Nucleic acid detection of HCV is performed to evaluate whether a patient has an ongoing or chronic HCV infection. DNA or RNA probing detects much lower levels of the infectious agent, sometimes even the presence of a single organism. Probing involves identifying the infectious agent's nucleic acid (DNA or RNA) by releasing it from the cell and extracting it through nucleic acid hybridization using a probe. A direct probe consists of laboratory-prepared, complimentary strands of nucleic acid, often labeled with chemical fluorescence, specifically designed to align and bind with the target nucleic acid to form stable, double-stranded complexes or hybrids. Amplified probing provides greater sensitivity for more direct, qualitative detection by using techniques such as reverse transcription polymerase chain reaction (RT-PCR) to enzymatically replicate certain target sequences or positions in the nucleic acid which allows exponential amplification of the original target nucleic acid. An amplification primer is used in addition to the probe. Primers are artificial, short strands of nucleic acid complementary to the beginning or end of the nucleic acid fragment to be amplified. The primer adheres to the target nucleic acid at these points. The polymerase enzyme copies the region and builds the new nucleic acid. Following amplification, the amount of the infectious agent in the sample may be evaluated using reverse transcription and quantification. Quantification is performed to evaluate the severity of the infection and response to treatment.
52% lower than market
Lab analysis to screen for autoimmune disorders [HCPCS 86038]
Lab analysis to screen for autoimmune disorders [HCPCS 86038]
A blood sample is obtained to screen for the presence of antinuclear antibodies (ANA) or to measure the concentration of antinuclear antibody in the blood, which is referred to as an ANA titer. Antinuclear antibodies are auto-antibodies that bind to structures within the nucleus of cells. Auto-antibodies are a type of antibody that is directed against the body's own tissues. The presence and concentration of antinuclear antibodies may indicate one of several autoimmune disorders that cause inflammation of body tissues including systemic lupus erythematosus, Sjorgren's syndrome, rheumatoid arthritis, polymyositis, scleroderma, Hashimoto's thyroiditis, juvenile diabetes mellitus, Addison disease, vitiligo, pernicious anemia, glomerulonephritis, and pulmonary fibrosis. When testing for antinuclear antibodies, the specimen is typically screened first using an enzyme-linked immunosorbent assay (ELISA) If the screening test is positive, that is if antinuclear antibodies are detected, a titer is then obtained. An antinuclear antibody titer is performed by diluting the blood sample with increasing amounts of a saline solution and retesting until antinuclear antibodies are no longer detectable. ANA titer is expressed as 1:10, 1:20, 1:40, 1:80, etc, with the 1 indicating 1 part blood and the second number indicating the parts of saline solution. A higher second number indicates a higher concentration of antinuclear antibodies in the blood.
19% lower than market
Lab analysis to measure the amount of protein in serum specimen [HCPCS 84165]
Lab analysis to measure the amount of protein in serum specimen [HCPCS 84165]
A blood test is performed to measure protein levels in serum. This test is often performed in conjunction with total protein to detect pathophysiologic states such as inflammation, gammopathies, and dysproteinemias. There are more sensitive tests available to detect these and similar disorders. A blood sample is obtained by separately reportable venipuncture. Serum is tested using electrophoretic fractionation and quantitation.
56% lower than market
Lab analysis to screen for pathogenic organisms [HCPCS 87081]
Lab analysis to screen for pathogenic organisms [HCPCS 87081]
This test is performed when a specific pathogen is suspected. A blood sample is taken and placed in a medium conducive to the growth of the suspected pathogen. Any colonies that grow in the medium are then examined.
59% lower than market
Lab analysis to measure the amount of substance by other immunoassay technique [HCPCS 83520]
Lab analysis to measure the amount of substance by other immunoassay technique [HCPCS 83520]
15% lower than market
Lab analysis to screen for syphilis [HCPCS 86592]
Lab analysis to screen for syphilis [HCPCS 86592]
A test for syphilis is performed. Syphilis is a sexually-transmitted disease (STD) caused by the bacterium Treponema pallidum. During the primary stage, a sore called a chancre appears at the site where the syphilis bacterium entered the body. The chancre resolves without treatment in 3-6 weeks but the patient remains infected. Without treatment, the infection will progress to a secondary stage in which a skin rash and mucous membrane lesions appear. The most common site of the rash is the palms of the hands and soles of the feet. Other symptoms during the secondary stage include fever, swollen lymph nodes, sore throat, hair loss, headaches, weight loss, muscle aches, and fatigue. Symptoms of secondary syphilis also resolve spontaneously but the patient remains infected. The patient then enters the late or latent stage of the disease. Symptoms of this stage may not appear for 10-20 years. Symptoms of late stage syphilis include difficulty coordinating muscle movements, paralysis, numbness, gradual blindness, and dementia. These symptoms occur as the disease damages internal organs including the brain, nerves, eyes, heart, blood vessels, liver, bones, and joints. Of particular concern is undiagnosed syphilis infection during pregnancy as the infection can be passed to the baby in utero. This increases the risk of stillbirth or death shortly after birth. Untreated infants who survive often experience developmental delays or seizures. A qualitative syphilis test, such as the venereal disease research laboratory (VDRL) test, rapid plasma reagin (RPR) test, or automated reagin test (ART). The VDRL, RPR, ART are nontreponemal tests that measure antibody response to lipoidal antigen from T. pallidum and/or antibody interaction with host tissues. If a screening test is positive and the result is confirmed with a second confirmatory test, quantitative testing is then performed to determine disease activity and monitor response to treatment. Quantitative testing may be performed by enzyme linked immunosorbent assay (ELISA).
71% lower than market
Lab analysis to measure the amount of tacrolimus in blood specimen [HCPCS 80197]
Lab analysis to measure the amount of tacrolimus in blood specimen [HCPCS 80197]
A blood test is performed to measure tacrolimus levels. Tacrolimus, also known as Prograf is an immunosuppressant drug that affects the ability of certain white blood cells in the body to recognize and respond to transplanted body organs such as kidney, liver, heart and lung. The drug is administered intravenously, either alone or in combination with other immunosuppressant drugs. Tacrolimus has a narrow therapeutic range and blood levels may be assessed daily at the start of therapy, taper to 1-2 times per week and finally to once every 1-2 months. For routine monitoring the specimen is collected as a trough level, immediately prior to a scheduled dose and at least 12 hours after the previous dose. A blood sample is obtained by a separately reportable venipuncture. Whole blood is then tested using liquid chromatography-tandem mass spectrometry. Prograf may be tested with chromatographic or immunoassay technique and the results will be somewhat different. Make note of the technique used when comparing results with previous levels.
11% higher than market
Lab blood analysis to confirm blood unit compatibility by immediate spin technique [HCPCS 86920]
Lab blood analysis to confirm blood unit compatibility by immediate spin technique [HCPCS 86920]
A laboratory test is performed to determine the donor-recipient compatibility of a unit of blood. Compatibility testing may also be referred to as cross matching (CM). Immediate spin technique (ISCM) mixes recipient plasma or serum with donor red cells, centrifuges them immediately, and observes any hemolysis and/or agglutination. ISCM will not detect all ABO incompatibilities; however, a negative result indicates the blood of the donor and recipient are compatible and the unit may be transfused.
46% lower than market
Lab analysis to measure the amount of total digoxin in blood specimen [HCPCS 80162]
Lab analysis to measure the amount of total digoxin in blood specimen [HCPCS 80162]
A laboratory test is performed to measure digoxin levels. Digoxin, also known as Lanoxin, is a cardiac glycoside that controls sodium and potassium levels in the cells. Digoxin is primarily prescribed to treat atrial fibrillation, atrial flutter, and congestive heart failure. The drug increases the strength of cardiac muscle contractions which increases cardiac output and lowers the heart rate and venous pressure. Digoxin has a narrow therapeutic window but antidotal treatment is available (Digibind, Digoxin Immune FAB). The test for total digoxin measures Fab fragment-bound (inactive) digoxin and free (active) digoxin. This test is primarily used to monitor digoxin therapy and should be drawn 8-12 hours following an oral dose. The test for free digoxin (80163) may be used to evaluate breakthrough digoxin toxicity in patients with renal failure, access the need for additional antidigoxin Fab, determine when to reintroduce digoxin therapy, and monitor patients with possible digoxin-like immune reactive factors. To measure free digoxin, a blood sample is obtained by separately reportable venipuncture 6-8 hours after the last dose. Serum is tested for total digoxin using immunoassay and for free digoxin using ultrafiltration followed by electrochemiluminescent immunoassay.
1% lower than market
Lab blood analysis to identify antigens on red blood cell surface and determine the patient's blood group type (ABO) [HCPCS 86900]
Lab blood analysis to identify antigens on red blood cell surface and determine the patient's blood group type (ABO) [HCPCS 86900]
A blood specimen is tested to determine blood type (ABO) or Rh(D). Blood is grouped using an ABO blood typing system which identifies four blood types: type A, B, AB, or O. The blood sample is mixed with antibodies against Type A and B blood and then checked to determine if the blood cells agglutinate, or stick together. Type A blood has anti-B antibodies; type B blood has anti-A antibodies; type O blood has antibodies to both A and B; and type AB blood does not have anti-A or anti-B antibodies. Type A blood agglutinates when type B antibodies are introduced. Type B blood agglutinates when type A antibodies are introduced. Type O blood agglutinates when type A or B antibodies are introduced. Type AB blood does not agglutinate when type A or B antibodies are introduced. The blood is then back typed. Blood serum is mixed with blood that is known to be type A or B.
24% lower than market
Lab blood analysis to screen for antibodies to red blood cell antigens (each serum technique) [HCPCS 86850]
Lab blood analysis to screen for antibodies to red blood cell antigens (each serum technique) [HCPCS 86850]
A blood sample is tested for antibodies directed against red blood cell (RBC) antigens other than A and B antigens. This test may also be referred to as an indirect antiglobulin test (IAT). This test is performed as part of a blood typing and screening test when it is anticipated that a blood transfusion might be required. If an antibody is detected, then separately reportable antibody identification is performed to identify the specific antibodies present. The test may be performed using IAT methodology or another serum technique such as solid phase. If multiple serum techniques are used, each reported separately.
29% lower than market
Lab analysis to measure the amount of total phenytoin in blood specimen [HCPCS 80185]
Lab analysis to measure the amount of total phenytoin in blood specimen [HCPCS 80185]
A blood test is performed to measure phenytoin total and phenytoin free levels. Phenytoin also known as Dilantin, Phenytek or Prompt, is an anticonvulsant prescribed to treat seizures and works by deceasing electrical activity in the brain. The drug may be administered orally or by injection. Phenytoin has a narrow therapeutic range and the patient should be monitored for both total and free phenytoin levels. Total phenytoin reflects the total serum concentration of the drug while free phenytoin levels reflect the unbound levels. Only the unbound levels are biologically active. Ninety (90) percent of the drug is typically highly bound and biologically inactive, but bound phenytoin is sensitive to displacement by other protein binding drugs which can elevate levels of free phenytoin in the blood. Blood concentration levels are monitored at regular intervals and also when breakthrough seizures occur, indicating possible low therapeutic levels. A blood sample is obtained by a separately reportable venipuncture. Blood serum is then tested using immunoassay.
58% lower than market
Platelet pheres leukoreduced [HCPCS P9035]
Platelet pheres leukoreduced [HCPCS P9035]
65% lower than market
Lab analysis to measure the amount of troponin (protein) in serum specimen [HCPCS 84484]
Lab analysis to measure the amount of troponin (protein) in serum specimen [HCPCS 84484]
A blood test is performed to measure troponin levels. Troponins are regulatory proteins that facilitate contraction of skeletal and smooth muscle by forming calcium bonds. Troponin T binds to tropomyosin to form a complex. Troponin I binds to actin and holds the Troponin T-tropomyosin complex together. Elevation of troponins, coupled with cardiac symptoms such as chest pain are considered diagnostic for cardiac injury. This test is commonly ordered in the Emergency Department when a patient presents with possible myocardial infarction, and is then repeated at 6 hour intervals. It may be ordered with other tests that assess cardiac biomarkers such as CK, CK-MB, and myoglobin. A blood sample is obtained by separately reportable venipuncture. Serum/plasma is tested for Troponin T using quantitative electrochemiluminescent immunoassay. Serum is tested for Troponin I using chemiluminescent immunoassay.
4% lower than market
Rbc leukocytes reduced [HCPCS P9016]
Rbc leukocytes reduced [HCPCS P9016]
Red blood cells, leukocytes reduced, each unit
49% lower than market
Lab analysis to measure the amount of vancomycin (antibiotic) in serum specimen [HCPCS 80202]
Lab analysis to measure the amount of vancomycin (antibiotic) in serum specimen [HCPCS 80202]
A blood test is performed to measure vancomycin levels at random, peak and trough times. Vancomycin, also known as Vancocin is a glycopeptide antibiotic prescribed to treat severe or serious bacterial infections. For systemic infections it is administered by intravenous infusion. For intestinal infections such as colitis or clostridium difficile it is taken orally. Blood level monitoring is necessary because the drug has the potential to cause auditory toxicity. A random sample may be drawn any time, peak and trough levels are time dependant and are usually drawn 24 hours after initiating therapy and every 2-3 days thereafter. A trough level is drawn 10 minutes prior to intravenous infusion. A peak level is drawn 1-2 hours after intravenous infusion is complete. A blood sample is obtained by separately reportable venipuncture. Blood serum is then tested using fluorescence polarization immunoassay.
56% lower than market
Unlisted lab analysis by immunoassay for identification of organism [HCPCS 87899]
Unlisted lab analysis by immunoassay for identification of organism [HCPCS 87899]
86% higher than market
Lab analysis to measure the amylase (enzyme) level in serum specimen [HCPCS 82150]
Lab analysis to measure the amylase (enzyme) level in serum specimen [HCPCS 82150]
Laboratory testing for amylase may be performed on blood, urine, and other body fluids. Amylase is an enzyme responsible for the break down of starches into sugar molecules (disaccharides and trisaccharides) and eventually into glucose for energy use by the cells. Amylase is produced in saliva and the pancreas. Abnormal amylase levels may result from pancreatic inflammation or trauma, perforated peptic ulcer, ovarian cyst (torsion), strangulation ileus, macroamylasemia, mumps, and cystic fibrosis. A blood or body fluid sample is obtained. The sample is then tested using quantitative enzymatic methodology.
15% lower than market
Lab analysis to measure the blood potassium level in blood specimen [HCPCS 84132]
Lab analysis to measure the blood potassium level in blood specimen [HCPCS 84132]
A blood sample is obtained to measure potassium level. Potassium is a positively charged electrolyte that works in conjunction with other electrolytes, such as sodium, chloride, and carbon dioxide (CO2), to regulate body fluid, stimulate muscle contraction, and maintain proper acid-base balance. Potassium is found in all body fluids but mostly stored within cells, not in extracellular fluids, blood serum, or plasma. Small fluctuations in blood potassium, either too high (hyperkalemia) or too low (hypokalemia), can have serious, even life-threatening, consequences. Potassium level is used to screen for and monitor renal disease; monitor patients on certain medications, such as diuretics, as well as patients with acute and chronic conditions, such as dehydration or endocrine disorders. Because blood potassium affects heart rhythm and respiratory rate, it is routinely checked prior to major surgical procedures. Potassium is measured by ion-selective electrode (ISE) methodology.
118% higher than market
Lab analysis to measure the creatine kinase (cardiac enzyme) level (MB fraction only) [HCPCS 82553]
Lab analysis to measure the creatine kinase (cardiac enzyme) level (MB fraction only) [HCPCS 82553]
Creatine kinase (CK) also known as, creatine phosphokinase (CPK), is an enzyme found in the heart, brain, skeletal muscle and certain other tissue. The subtypes are known as CK-MM found primarily in skeletal and heart muscle, CK-MB found in heart muscle and CK-BB located in the brain. CK circulating in blood rarely contains CK-BB but is largely comprised of CK-MM or CK-MB. Levels may be elevated following heart muscle damage (heart attack/myocardial infarction) and skeletal muscle injury (trauma, vigorous exercise). Statin drugs that lower cholesterol level and alcohol intake may cause elevated CK blood levels. Only creatine kinase (CK) MB fraction is measured. Testing for this isoenzyme can help identify heart muscle damage following a heart attack (myocardial infarction). A blood test is obtained by separately reportable venipuncture. Serum is tested using chemiluminescent immunoassay.
8% lower than market
Lab analysis to measure the creatinine level in blood specimen to test for kidney function or muscle injury [HCPCS 82565]
Lab analysis to measure the creatinine level in blood specimen to test for kidney function or muscle injury [HCPCS 82565]
A blood sample is taken to measure creatinine levels. Creatinine is a waste product produced by the muscles in the breakdown of creatine, which is a compound used by the muscles to create energy for contraction. The waste product, creatinine, is excreted by the kidneys and blood levels provide a good measurement of renal function. Creatinine may be checked to screen for or monitor treatment of renal disease. Creatinine levels may also be monitored in patients with acute or chronic illnesses that may impair renal function and in patients on medications that affect renal function. Creatinine is measured using spectrophotometry.
95% higher than market
Lab analysis to measure the creatinine level to test for kidney function or muscle injury (other than blood specimen) [HCPCS 82570]
Lab analysis to measure the creatinine level to test for kidney function or muscle injury (other than blood specimen) [HCPCS 82570]
A sample other than blood is taken to measure creatinine levels. Creatinine is a waste product produced by the muscles in the breakdown of creatine, which is a compound used by the muscles to create energy for contraction. The waste product, creatinine, is excreted by the kidneys and blood levels provide a good measurement of renal function. Creatinine may be checked to screen for or monitor treatment of renal disease. Creatinine levels may also be monitored in patients with acute or chronic illnesses that may impair renal function and in patients on medications that affect renal function. Creatinine clearance, also known as urea or urea nitrogen clearance tests both blood and urine samples for a calculation of creatinine content adjusted for urine volume and physical size as a general indicator of glomerular filtration function.
68% lower than market
Lab analysis to measure the cyanocobalamin (vitamin b-12) level [HCPCS 82607]
Lab analysis to measure the cyanocobalamin (vitamin b-12) level [HCPCS 82607]
Cyanocobalamin is a vitamer of the B-12 vitamin family and plays an important role in metabolism, red blood cell production and nervous system function. Blood levels of cyanocobalamin are measured. Blood levels may be reduced with pernicious and other forms of anemia, and in individuals who follow a strict vegan diet, have chronic infections (such as HIV) and during pregnancy. A blood sample is obtained by separately reportable venipuncture. Serum is tested using quantitative chemiluminescent immunoassay.
3% lower than market
Lab analysis to measure the ferritin (blood protein) level [HCPCS 82728]
Lab analysis to measure the ferritin (blood protein) level [HCPCS 82728]
A blood test is performed to measure ferritin levels. Ferritin is an intracellular protein that stores iron and releases it into circulation in a controlled manner to protect the body against iron overload and iron deficiency. Ferritin levels may be obtained to evaluate for elevated levels caused by excess storage diseases such as hemochromatosis and following multiple transfusions. Levels may also be obtained to evaluate for decreased levels due to iron deficiency. A blood sample is obtained by separately reportable venipuncture. Serum is tested using quantitative chemiluminescent immunoassay.
25% higher than market
Lab analysis to measure the folic acid level in serum specimen [HCPCS 82746]
Lab analysis to measure the folic acid level in serum specimen [HCPCS 82746]
A blood test is performed to measure folic acid (folate) levels in serum or red blood cells (RBC). Folic acid (folate) may also be referred to as Vitamin B9 and is essential for the growth, division and repair of cells, especially fetal growth during pregnancy and in early infancy. It is also necessary for the production of healthy red blood cells and to prevent anemia at all ages. The test may be used to diagnose anemia or certain neuropathies and to monitor the effectiveness of treatment for these conditions. A blood sample is obtained by separately reportable venipuncture.
4% lower than market
Lab analysis to measure the glutamyltransferase (liver enzyme) level [HCPCS 82977]
Lab analysis to measure the glutamyltransferase (liver enzyme) level [HCPCS 82977]
A blood test is performed to measure gamma glutamyltransferase (GGT) levels. GGT is an enzyme that assists with the transfer of amino acids across cell membranes, including cells found in the liver, kidney, pancreas, heart, brain, and seminal vesicles. GGT levels are used as a diagnostic marker for certain diseases of the liver, bile ducts, and pancreas. A blood sample is obtained by separately reportable venipuncture. Serum or plasma is tested using quantitative enzymatic methodology.
29% higher than market
Lab analysis to measure the hemoglobin A1C level in blood specimen [HCPCS 83036]
Lab analysis to measure the hemoglobin A1C level in blood specimen [HCPCS 83036]
A blood test is performed to measure glycosylated hemoglobin (HbA1C) levels. Plasma glucose binds to hemoglobin and the HbA1C test measures the average plasma glucose concentration over the life of red blood cells (approximately 90-120 days). HbA1C levels may be used as a diagnostic reference for patients with suspected diabetes mellitus (DM) and to monitor blood glucose control in patients with known DM. HbA1C levels should be monitored at least every 6 months in patients with DM and more frequently when the level is >7.0%. A blood sample is obtained by separately reportable venipuncture. Whole blood is tested using quantitative high performance liquid chromatography/boronate affinity.
30% lower than market
Lab analysis to measure the ionized calcium level in blood specimen [HCPCS 82330]
Lab analysis to measure the ionized calcium level in blood specimen [HCPCS 82330]
A blood sample is taken to measure the amount of ionized or free calcium. Ionized or free calcium is calcium that flows freely in the blood and is not attached to any proteins. Ionized calcium is metabolically active and available to support and regulate heart function, muscle contraction, central nervous system function, and blood clotting. Ionized calcium measurements may be obtained prior to major surgery, in critically ill patients, or when protein levels are abnormal. Ionized calcium is measured by ion selective electrode (ISE) or pH electrode methodology.
2% higher than market
Lab analysis to measure the iron binding capacity [HCPCS 83550]
Lab analysis to measure the iron binding capacity [HCPCS 83550]
A blood test is performed to measure the iron binding capacity of transferrin. Transferrin, a protein found in circulating blood is responsible for carrying iron molecules. This test measures the ability of transferrin to carry iron. A blood sample is obtained by separately reportable venipuncture. Serum or plasma is tested using quantitative spectrophotometry/calculation.
21% higher than market
Lab analysis to measure the iron level [HCPCS 83540]
Lab analysis to measure the iron level [HCPCS 83540]
A blood, urine or liver test is performed to measure iron levels. Iron (Fe) is an essential element that circulates in the blood attached to the protein transferrin. Iron is necessary component of hemoglobin, found in red blood cells (RBCs) and myoglobin found in muscle cells. Low iron levels may cause a decrease in red blood cells and iron deficiency anemia. High iron levels may be caused by excessive intake of iron supplements or a hereditary genetic condition such as hemochromatosis from a mutation of the RGMc gene or HAMP gene. A blood sample is obtained by separately reportable venipuncture. Serum or plasma is tested using quantitative spectrophotometry. A random voided or 24 hour urine specimen is obtained and tested using quantitative inductively coupled plasma/emission spectrometry. Patient should wait 2-4 days after receiving iodine or gadolinium contrast media to collect a urine specimen. A liver sample is obtained by a separately reportable procedure. Liver tissue is tested using quantitative inductively coupled plasma-mass spectrometry.
29% higher than market
Lab analysis to measure the lactate dehydrogenase (enzyme) level [HCPCS 83615]
Lab analysis to measure the lactate dehydrogenase (enzyme) level [HCPCS 83615]
A blood or body fluid test is performed to measure lactate dehydrogenase (LD) (LDH) levels. LDH is an enzyme present in red blood cells (RBCs) and in the tissue of heart, liver, pancreas, kidney, skeletal muscle, brain and lungs. LDH levels are used as a marker for tissue and RBC damage. Elevated blood levels can be caused by stroke, myocardial infarction, liver disease, pancreatitis, muscular dystrophy, infectious mononucleosis, hemolytic anemia and tumors/cancers such as lymphoma. Elevated cerebral spinal fluid (CSF) levels are usually indicative of bacterial meningitis. LDH levels in pleural and/or pericardial fluid can indicate if the effusion is an exudate, caused by an infection or a transudate caused by fluid pressure problem. A blood sample is obtained by separately reportable venipuncture. Cerebral spinal fluid is obtained by separately reportable lumbar puncture (spinal tap). Pericardial fluid is obtained by separately reportable pericardiocentesis. Fluid from a pleural effusion is obtained by separately reportable thoracentesis. Serum or plasma and all body fluids are tested using quantitative enzymatic methodology.
13% higher than market
Lab analysis to measure the lactic acid level in blood, plasma, or cerbrospinal fluid specimen [HCPCS 83605]
Lab analysis to measure the lactic acid level in blood, plasma, or cerbrospinal fluid specimen [HCPCS 83605]
A blood or body fluid test is performed to measure lactate (lactic acid) levels. Lactic acid is produced primarily by muscle tissue and red blood cells in the body. Elevated levels may be caused by strenuous exercise, heart failure, severe infection (sepsis), shock states (cardiogenic, hypovolemic) and liver disease. A blood sample is obtained by separately reportable venipuncture. Cerebral spinal fluid (CSF) is obtained by lumbar puncture (spinal tap). Other body fluids may also be collected and tested. Plasma, CSF, and other body fluids are tested using enzymatic methodology.
54% lower than market
Lab analysis to measure the LDL cholesterol level [HCPCS 83721]
Lab analysis to measure the LDL cholesterol level [HCPCS 83721]
Lab test for LDL Cholesterol
19% lower than market
Lab analysis to measure the lipase (fat enzyme) level [HCPCS 83690]
Lab analysis to measure the lipase (fat enzyme) level [HCPCS 83690]
A test is performed on blood and body fluids to measure lipase levels. Lipase is an enzyme released by the pancreas into the small intestine and is essential for the digestion of dietary fats. Elevated levels may result from small bowel obstruction, celiac disease, cholecystitis, duodenal ulcer, severe gastroenteritis, macrolipasemia, pancreatitis, and pancreatic tumors. The test may be ordered when there is a family history of lipoprotein lipase deficiency. A blood sample is obtained by separately reportable venipuncture. Other body fluids collected by other methods. Blood and other body fluids are tested using quantitative enzymatic methodology.
51% lower than market
Lab analysis to measure the magnesium level in body fluids and cells [HCPCS 83735]
Lab analysis to measure the magnesium level in body fluids and cells [HCPCS 83735]
A blood, urine, or fecal test is performed to measure magnesium levels. Magnesium is an essential dietary mineral responsible for enzyme function, energy production, and contraction and relaxation of muscle fibers. Decreased levels may result from severe burns, metabolic disorders, certain medications, and low blood calcium levels. A blood sample is obtained by separately reportable venipuncture. Red blood cells (RBCs) are tested using quantitative inductively coupled plasma-mass spectrometry. Serum/plasma is tested using quantitative spectrophotometry. A 24-hour voided urine specimen is tested using quantitative spectrophotometry. A random or 24-hour fecal sample is tested using quantitative spectrophotometry.
6% higher than market
Lab analysis to measure the microalbumin (protein) level in urine specimen [HCPCS 82043]
Lab analysis to measure the microalbumin (protein) level in urine specimen [HCPCS 82043]
A test on urine is used to measure microalbumin levels and is routinely performed annually on diabetic patients with stable blood glucose levels to assess for early onset nephropathy. The quantitative test, which measures the actual amount of microalbumin present in the urine, may be performed on a random urine sample, with a notation of total volume and voiding time, or a 24-hour urine sample using immunoturbidimetric technique. The semi-quantitative test identifies the presence of elevated microalbumin levels in the urine within a general range and involves a chemical dipstick placed into the urine sample which reacts and changes color when albumin is present.
65% higher than market
Lab analysis to measure the natriuretic peptide (heart and blood vessel protein) level in plasma specimen [HCPCS 83880]
Lab analysis to measure the natriuretic peptide (heart and blood vessel protein) level in plasma specimen [HCPCS 83880]
The level of the natriuretic peptide in the blood is measured to evaluate heart failure and to differentiate symptoms that might be indicative of heart failure from other disorders that cause similar symptoms. A separately reportable venipuncture is performed and whole blood or plasma collected using EDTA as an anticoagulant. An automated immunoassay is performed using murine monoclonal and polyclonal antibodies against natriuretic peptide. The antibodies are labeled with a fluorescent dye and immobilized on the solid phase. The specimen is placed in the sample chamber and the analysis is run. The physician reviews the results and uses them to make diagnosis and treatment decisions.
31% lower than market
Harbor Regional Health Patient Information Price List
OUTPATIENT MEDICINE
OUTPATIENT MEDICINE
Description
Variance
Catheter, guiding [HCPCS C1887]
Catheter, guiding [HCPCS C1887]
8% lower than market
Chemotherapy administration into vein by infusion (each additional hour) [HCPCS 96415]
Chemotherapy administration into vein by infusion (each additional hour) [HCPCS 96415]
34% lower than market
Drug administration into vein by infusion for therapy, prevention, or diagnosis (concurrent with another infusion) [HCPCS 96368]
Drug administration into vein by infusion for therapy, prevention, or diagnosis (concurrent with another infusion) [HCPCS 96368]
An intravenous infusion of a specified substance or drug is administered for therapy, prophylaxis, or diagnosis. An intravenous line is placed into a vein, usually in the arm, and the specified substance or drug is administered. The physician provides direct supervision of the administration and is immediately available to intervene should complications arise. The physician provides periodic assessments of the patient and documentation of the patient's response to treatment.
11% lower than market
Drug administration into vein by infusion for therapy, prevention, or diagnosis (up to 1 hour) [HCPCS 96365]
Drug administration into vein by infusion for therapy, prevention, or diagnosis (up to 1 hour) [HCPCS 96365]
An intravenous infusion of a specified substance or drug is administered for therapy, prophylaxis, or diagnosis. An intravenous line is placed into a vein, usually in the arm, and the specified substance or drug is administered. The physician provides direct supervision of the administration and is immediately available to intervene should complications arise. The physician provides periodic assessments of the patient and documentation of the patient's response to treatment.
38% lower than market
Drug administration into vein by infusion of additional sequential infusion of new drug for therapy, prevention, or diagnosis (up to 1 hour) [HCPCS 96367]
Drug administration into vein by infusion of additional sequential infusion of new drug for therapy, prevention, or diagnosis (up to 1 hour) [HCPCS 96367]
An intravenous infusion of a specified substance or drug is administered for therapy, prophylaxis, or diagnosis. An intravenous line is placed into a vein, usually in the arm, and the specified substance or drug is administered. The physician provides direct supervision of the administration and is immediately available to intervene should complications arise. The physician provides periodic assessments of the patient and documentation of the patient's response to treatment.
4% higher than market
Hbot, full body chamber, 30m [HCPCS G0277]
Hbot, full body chamber, 30m [HCPCS G0277]
89% lower than market
Heart and lungs restart (attempt) [HCPCS 92950]
Heart and lungs restart (attempt) [HCPCS 92950]
Cardiopulmonary resuscitation (CPR) is a manual attempt at restarting a patient's heart and lungs when cardiopulmonary arrest occurs. Typically led by a health care provided certified in CPR, the lungs are filled with air by holding the nose and breathing through the mouth or performed with a ventilating bag. Chest compressions are also performed at intervals, alternating with the air in the lungs. A defibrillator may be used to shock the heart into starting.
37% higher than market
Hydration administration into vein by infusion (31 minutes to 1 hour) [HCPCS 96360]
Hydration administration into vein by infusion (31 minutes to 1 hour) [HCPCS 96360]
An intravenous infusion is administered for hydration. An intravenous line is placed into a vein, usually in the arm, and fluid is administered to provide additional fluid levels and electrolytes to counteract the effects of dehydration or supplement deficient oral fluid intake. The physician provides direct supervision of the fluid administration and is immediately available to intervene should complications arise. The physician provides periodic assessments of the patient and documentation of the patient's response to treatment.
12% lower than market
Hydration administration into vein by infusion (each additional hour) [HCPCS 96361]
Hydration administration into vein by infusion (each additional hour) [HCPCS 96361]
An intravenous infusion is administered for hydration. An intravenous line is placed into a vein, usually in the arm, and fluid is administered to provide additional fluid levels and electrolytes to counteract the effects of dehydration or supplement deficient oral fluid intake. The physician provides direct supervision of the fluid administration and is immediately available to intervene should complications arise. The physician provides periodic assessments of the patient and documentation of the patient's response to treatment. Use 96360 for the initial 31 minutes to one hour of hydration. Use 96361 for each additional hour.
33% lower than market
Implanted venous access drug delivery device irrigation [HCPCS 96523]
Implanted venous access drug delivery device irrigation [HCPCS 96523]
51% lower than market
Moderate conscious sedation services by physician also performing a procedure (each additional 15 minutes) [HCPCS 99153]
Moderate conscious sedation services by physician also performing a procedure (each additional 15 minutes) [HCPCS 99153]
57% lower than market
Orthotics use training (supports, braces, or splints) for arms, legs and/or trunk (initial encounter, each 15 minutes) [HCPCS 97760]
Orthotics use training (supports, braces, or splints) for arms, legs and/or trunk (initial encounter, each 15 minutes) [HCPCS 97760]
7% higher than market
Physician services for outpatient heart rehab with continuous EKG monitoring (per session) [HCPCS 93798]
Physician services for outpatient heart rehab with continuous EKG monitoring (per session) [HCPCS 93798]
49% lower than market
Respiratory inhaled aerosol treatment to relieve airway obstruction (first hour) [HCPCS 94644]
Respiratory inhaled aerosol treatment to relieve airway obstruction (first hour) [HCPCS 94644]
11% lower than market
Swallowing function evaluation by fluoroscopy with video recording [HCPCS 92611]
Swallowing function evaluation by fluoroscopy with video recording [HCPCS 92611]
28% lower than market
Tissue removal from wounds per session (first 20 sq cm or less) [HCPCS 97597]
Tissue removal from wounds per session (first 20 sq cm or less) [HCPCS 97597]
38% lower than market
Wound vac therapy (negative pressure wound therapy) with DME (durable medical equipment) per session (surface area less than or equal to 50 square cm) [HCPCS 97605]
Wound vac therapy (negative pressure wound therapy) with DME (durable medical equipment) per session (surface area less than or equal to 50 square cm) [HCPCS 97605]
35% lower than market
Harbor Regional Health Patient Information Price List
OUTPATIENT OTHER
OUTPATIENT OTHER
Description
Variance
Non-covered item or service [HCPCS A9270]
Non-covered item or service [HCPCS A9270]
363% higher than market
Tomosynthesis, mammo [HCPCS G0279]
Tomosynthesis, mammo [HCPCS G0279]
67% lower than market
Harbor Regional Health Patient Information Price List
OUTPATIENT PHARMACY AND DRUG ADMINISTRATION
OUTPATIENT PHARMACY AND DRUG ADMINISTRATION
Description
Variance
5% dextrose/water [HCPCS J7060]
5% dextrose/water [HCPCS J7060]
14% higher than market
Adenosine inj 1mg [HCPCS J0153]
Adenosine inj 1mg [HCPCS J0153]
12% higher than market
Adrenalin epinephrine inject [HCPCS J0171]
Adrenalin epinephrine inject [HCPCS J0171]
Injection, adrenalin, epinephrine, 0.1 mg
68% lower than market
Chemotherapy administration into vein by infusion (up to 1 hour, single drug) [HCPCS 96413]
Chemotherapy administration into vein by infusion (up to 1 hour, single drug) [HCPCS 96413]
An intravenous infusion of a chemotherapy substance or drug is administered for treatment of a malignant neoplasm. An intravenous line is placed into a vein, usually in the arm, and the specified chemotherapy agent is administered. The physician provides direct supervision of the administration of the chemotherapy agent and is immediately available to intervene should complications arise. The physician provides periodic assessments of the patient and documentation of the patient's response to treatment.
46% lower than market
Darbepoetin alfa, non-esrd [HCPCS J0881]
Darbepoetin alfa, non-esrd [HCPCS J0881]
51% higher than market
Drug administration into vein by push technique for therapy, diagnosis, or prevention (each additional push of new drug) [HCPCS 96375]
Drug administration into vein by push technique for therapy, diagnosis, or prevention (each additional push of new drug) [HCPCS 96375]
A therapeutic, prophylactic, or diagnostic injection is administered by intravenous push (IVP) technique. The specified substance or drug is injected using a syringe directly into an injection site of an existing intravenous line or intermittent infusion set (saline lock). The injection is given over a short period of time, usually less than 15 minutes.
49% lower than market
Drug administration into vein by push technique for therapy, diagnosis, or prevention (initial drug) [HCPCS 96374]
Drug administration into vein by push technique for therapy, diagnosis, or prevention (initial drug) [HCPCS 96374]
A therapeutic, prophylactic, or diagnostic injection is administered by intravenous push (IVP) technique. The specified substance or drug is injected using a syringe directly into an injection site of an existing intravenous line or intermittent infusion set (saline lock). The injection is given over a short period of time, usually less than 15 minutes.
14% lower than market
Furosemide injection [HCPCS J1940]
Furosemide injection [HCPCS J1940]
Injection, furosemide, up to 20 mg
3% higher than market
Hydralazine hcl injection [HCPCS J0360]
Hydralazine hcl injection [HCPCS J0360]
Injection, hydralazine hcl, up to 20 mg
11% lower than market
Inj ceftazidime per 500 mg [HCPCS J0713]
Inj ceftazidime per 500 mg [HCPCS J0713]
109% higher than market
Inj enoxaparin sodium [HCPCS J1650]
Inj enoxaparin sodium [HCPCS J1650]
Injection, enoxaparin sodium, 10 mg
38% lower than market
Inj heparin sodium per 1000u [HCPCS J1644]
Inj heparin sodium per 1000u [HCPCS J1644]
Injection, heparin sodium, per 1000 units
4% higher than market
Ketorolac tromethamine inj [HCPCS J1885]
Ketorolac tromethamine inj [HCPCS J1885]
Injection, ketorolac tromethamine, per 15 mg
45% lower than market
Levofloxacin injection [HCPCS J1956]
Levofloxacin injection [HCPCS J1956]
Injection, levofloxacin, 250 mg
3% higher than market
Meropenem [HCPCS J2185]
Meropenem [HCPCS J2185]
54% lower than market
Metoclopramide hcl injection [HCPCS J2765]
Metoclopramide hcl injection [HCPCS J2765]
Injection, metoclopramide hcl, up to 10 mg
4% lower than market
Morphine sulfate injection [HCPCS J2270]
Morphine sulfate injection [HCPCS J2270]
Injection, morphine sulfate, up to 10 mg
17% higher than market
Na ferric gluconate complex [HCPCS J2916]
Na ferric gluconate complex [HCPCS J2916]
68% higher than market
Neostigmine methylslfte inj [HCPCS J2710]
Neostigmine methylslfte inj [HCPCS J2710]
33% lower than market
Normal saline solution infus [HCPCS J7040]
Normal saline solution infus [HCPCS J7040]
39% lower than market
Normal saline solution infus [HCPCS J7050]
Normal saline solution infus [HCPCS J7050]
76% lower than market
Octreotide inj, non-depot [HCPCS J2354]
Octreotide inj, non-depot [HCPCS J2354]
1% higher than market
Ondansetron hcl injection [HCPCS J2405]
Ondansetron hcl injection [HCPCS J2405]
Injection, ondansetron hydrochloride, per 1 mg
4% higher than market
Succinycholine chloride inj [HCPCS J0330]
Succinycholine chloride inj [HCPCS J0330]
32% lower than market
Tc99m tetrofosmin [HCPCS A9502]
Tc99m tetrofosmin [HCPCS A9502]
3% higher than market
Thiamine hcl 100 mg [HCPCS J3411]
Thiamine hcl 100 mg [HCPCS J3411]
8% lower than market
Vitamin k phytonadione inj [HCPCS J3430]
Vitamin k phytonadione inj [HCPCS J3430]
109% higher than market
Harbor Regional Health Patient Information Price List
OUTPATIENT SURGICAL SERVICES
OUTPATIENT SURGICAL SERVICES
Description
Variance
Blood specimen collection from a completely implantable venous access device [HCPCS 36591]
Blood specimen collection from a completely implantable venous access device [HCPCS 36591]
71% lower than market
Blood specimen collection from central or peripheral venous catheter [HCPCS 36592]
Blood specimen collection from central or peripheral venous catheter [HCPCS 36592]
85% lower than market
Breast biopsy with ultrasound guidance (first lesion) [HCPCS 19083]
Breast biopsy with ultrasound guidance (first lesion) [HCPCS 19083]
51% lower than market
Breathing tube insertion into windpipe cartilage with endoscope (emergent) [HCPCS 31500]
Breathing tube insertion into windpipe cartilage with endoscope (emergent) [HCPCS 31500]
The mouth is opened and any dentures are removed. A laryngoscope is passed into the hypopharynx and the glottis and vocal cords are visualized. A properly sized endotracheal tube is selected and the balloon is inflated. A stylet is inserted into the endotracheal tube and the tube and stylet are bent into a crescent shape. The endotracheal tube and stylet are inserted alongside the laryngoscope into the trachea and positioned with the balloon lying just beyond the vocal cords. The stylet is removed and the endotracheal tube is connected to the ventilation device and secured with tape. Breath sounds are checked using a stethoscope to ensure that the endotracheal tube is properly positioned.
14% higher than market
Chemical agent application to wound tissue [HCPCS 17250]
Chemical agent application to wound tissue [HCPCS 17250]
54% lower than market
Collection of blood specimen from arterial puncture for diagnosis [HCPCS 36600]
Collection of blood specimen from arterial puncture for diagnosis [HCPCS 36600]
The radial artery is the most common site for arterial puncture with alternative sites being the axillary and femoral arteries. The arterial puncture site is selected. The skin is prepped for sterile entry. The selected artery is punctured and the necessary blood samples obtained for separately reportable laboratory studies. The needle is withdrawn and pressure applied to the puncture site.
28% higher than market
Complex cataract removal with lens insertion [HCPCS 66982]
Complex cataract removal with lens insertion [HCPCS 66982]
22% lower than market
Fluid removal from chest cavity with imaging guidance [HCPCS 32555]
Fluid removal from chest cavity with imaging guidance [HCPCS 32555]
68% lower than market
Large joint or joint capsule fluid removal and/or injection with needle [HCPCS 20610]
Large joint or joint capsule fluid removal and/or injection with needle [HCPCS 20610]
Arthrocentesis, aspiration, and/or injection of a joint or bursa is performed. Arthrocentesis and aspiration is performed to remove fluid from a joint or bursa in order to diagnose the cause of joint effusion and/or to reduce pain caused by the excess fluid. Injection of a joint or bursa may be performed in conjunction with the arthrocentesis procedure and is typically performed using an anti-inflammatory medication such as a steroid to reduce inflammation of the joint or bursa. The skin over the joint is cleansed. A local anesthetic is injected as needed. A needle with a syringe attached is inserted into the affected joint or bursa. Fluid is removed and sent for separately reportable laboratory analysis. This may be followed by a separate injection of medication into the joint or bursa.
45% lower than market
Needle insertion into vein for collection of blood sample [HCPCS 36415]
Needle insertion into vein for collection of blood sample [HCPCS 36415]
An appropriate vein is selected, usually one of the larger anecubital veins such as the median cubital, basilic, or cehalic veins. A tourniquet is placed above the planned puncture site. The site is disinfected with an alcohol pad. A needle is attached to a hub and the vein is punctured. A Vacuainer tube is attached to the hub and the blood specimen is collected. The Vacutainer tube is removed. Depending on the specific blood tests required, multiple Vacutainers may be filled from the same punchture site.
1% lower than market
Non-tunneled central venous catheter insertion for infusion (5 years of age or older) [HCPCS 36556]
Non-tunneled central venous catheter insertion for infusion (5 years of age or older) [HCPCS 36556]
9% lower than market
Short arm splint application forearm to hand (non-moveable) [HCPCS 29125]
Short arm splint application forearm to hand (non-moveable) [HCPCS 29125]
A static splint is applied to stabilize an injury by decreasing movement and providing support to the posterior aspect of the forearm, wrist, and hand. A stockinette is applied over the arm from the elbow to the wrist followed by padding over the stockinette. Plaster sheets cut to the appropriate length are then immersed in water and saturated. Excess water is gently squeezed out of the plaster. The plaster is applied to the posterior aspect of the forearm, wrist, and hand. The plaster is smoothed and molded. An elastic bandage is wrapped around the arm to secure the splint. The forearm may be placed in a sling.
43% lower than market
Simple repair of wound of scalp, neck, underarms, genitalia, trunk, arms, and/or legs (2.5 cm or less) [HCPCS 12001]
Simple repair of wound of scalp, neck, underarms, genitalia, trunk, arms, and/or legs (2.5 cm or less) [HCPCS 12001]
Simple repair of superficial wounds of the scalp, neck, axillae, external genitalia, trunk, and/or extremities is performed. The wound is cleansed and a local anesthetic is administered. The wound is inspected and determined to be superficial involving only the epidermis, dermis, or subcutaneous tissue without involvement of deeper tissues and without heavy contamination. A simple, one-layer closure using sutures, staples, or tissue adhesive is performed. Alternatively, chemical cautery or electrocautery may be used to treat the wound without closure.
26% lower than market
Simple repair of wound of scalp, neck, underarms, genitalia, trunk, arms, and/or legs (2.6 to 7.5 cm) [HCPCS 12002]
Simple repair of wound of scalp, neck, underarms, genitalia, trunk, arms, and/or legs (2.6 to 7.5 cm) [HCPCS 12002]
Simple repair of superficial wounds of the scalp, neck, axillae, external genitalia, trunk, and/or extremities is performed. The wound is cleansed and a local anesthetic is administered. The wound is inspected and determined to be superficial involving only the epidermis, dermis, or subcutaneous tissue without involvement of deeper tissues and without heavy contamination. A simple, one-layer closure using sutures, staples, or tissue adhesive is performed. Alternatively, chemical cautery or electrocautery may be used to treat the wound without closure.
5% higher than market
Skin and muscle removal (first 20 sq cm or less) [HCPCS 11043]
Skin and muscle removal (first 20 sq cm or less) [HCPCS 11043]
86% lower than market
Skin and tissue removal (first 20 sq cm or less) [HCPCS 11042]
Skin and tissue removal (first 20 sq cm or less) [HCPCS 11042]
83% lower than market
Skin substitute graft application to trunk, arms, and legs for wound up to 100 sq cm (first 25 sq cm) [HCPCS 15271]
Skin substitute graft application to trunk, arms, and legs for wound up to 100 sq cm (first 25 sq cm) [HCPCS 15271]
2% higher than market
Tendon covering incision [HCPCS 26055]
Tendon covering incision [HCPCS 26055]
36% lower than market
Tunneled central venous catheter insertion for infusion with implanted port beneath the skin (5 years of age or older) [HCPCS 36561]
Tunneled central venous catheter insertion for infusion with implanted port beneath the skin (5 years of age or older) [HCPCS 36561]
A tunneled centrally inserted central venous catheter (CVC) with a subcutaneous port is placed. A CVC must terminate in the subclavian, brachiocephalic, or iliac veins, the superior or inferior vena cava, or right atrium. A tunneled CVC is placed through a subcutaneous tunnel into the jugular, subclavian, or femoral vein or the inferior vena cava with the most common venous access site for tunneled devices being the jugular vein. Separately reportable imaging guidance may be used to access the venous entry site and/or to manipulate the catheter tip to the final central position. Local anesthesia is administered at the planned puncture site. Using a Seldinger technique to access the jugular vein, the skin and vein are punctured with a needle. A guidewire is inserted through the needle and advanced several centimeters. A subcutaneous pocket is then created for placement of the port. A subcutaneous tunnel is created from the venous access site to the subcutaneous pocket. An introducer sheath and dilator are advanced over the guidewire and the guidewire and dilator removed. The catheter is then advanced through the tunnel to the introducer sheath in the jugular vein and into the brachiocephalic vein, subclavian vein, superior vena cava or right atrium. Placement is checked by separately reportable radiographs. The catheter and port are connected and the port is placed in the subcutaneous pocket. The incision over the venous access site is closed. The port is sutured into place and the pocket is closed.
37% higher than market
Vein wound compression system application to lower leg below knee including ankle and foot [HCPCS 29581]
Vein wound compression system application to lower leg below knee including ankle and foot [HCPCS 29581]
73% lower than market
Abscess incision and drainage (simple procedure or single abscess) [HCPCS 10060]
Abscess incision and drainage (simple procedure or single abscess) [HCPCS 10060]
This skin is cleansed and local anesthetic injected as needed. A straight or elliptical incision is made spanning the entire area of fluctuance. Any pockets of pus are opened using blunt dissection. The abscess is drained and then irrigated with sterile solution.
17% higher than market
Blood or blood products transfusion [HCPCS 36430]
Blood or blood products transfusion [HCPCS 36430]
Blood and blood components include whole blood, platelets, packed red blood cells, and plasma products. Transfusions are performed to replace blood that is lost or depleted due to an injury, surgery, sickle cell disease, or treatment for a malignant neoplasm. Red blood cells are given to increase the number of blood cells that transport oxygen and nutrients throughout the body, platelets to control bleeding and improve blood clotting, and plasma to replace total blood volume and provide blood factors that improve blood clotting. The skin is prepped over the planned transfusion site and an intravenous line inserted. Any medication ordered by the physician is administered prior to the transfusion. The blood and/or blood components are administered. The patient is monitored during the transfusion for any signs of adverse reaction.
66% lower than market
Harbor Regional Health Patient Information Price List
OUTPATIENT PHYSICAL/OCCUPATIONAL/SPEECH THERAPY
OUTPATIENT PHYSICAL/OCCUPATIONAL/SPEECH THERAPY
Description
Variance
Elec stim other than wound [HCPCS G0283]
Elec stim other than wound [HCPCS G0283]
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care
1% lower than market
Function improvement activities with one-on-one contact between patient and provider (each 15 minutes) [HCPCS 97530]
Function improvement activities with one-on-one contact between patient and provider (each 15 minutes) [HCPCS 97530]
In a one-on-one physical therapy session, the provider instructs and assists the patient in therapeutic activities designed to address specific functional limitations. The therapeutic activities are specifically developed and modified for the patient. Dynamic/movement activities, also called kinetic activities, that are designed to improve functional performance such as lifting, bending, pushing, pulling, jumping and reaching are included in this service. For example, the patient may be given therapeutic activities to perform to improve the ability to sit, stand, and get out of bed after an injury without straining or risking reinjury. This code is reported for each 15 minutes of one-on-one therapeutic activity provided.
21% lower than market
Occupational therapy evaluation (typically 30 minutes) [HCPCS 97165]
Occupational therapy evaluation (typically 30 minutes) [HCPCS 97165]
An occupational therapy evaluation or re-evaluation is performed. Occupational therapy assists the patient in developing or regaining skills that allow independent functioning and enhance health and personal well-being. A patient history is taken that includes an occupational profile and medical and therapy history with review of records as well as an extensive review of physical, cognitive, or psychosocial elements related to current performance of daily activities. The occupational therapist evaluates the patient's physical functioning, mental, and/or neurobehavioral impairment and performs tests to identify functional limitations or performance deficits. Physical functioning is evaluated, including an evaluation of any musculoskeletal conditions that may impair function. The ability to perform basic activities of daily living such as dressing, bathing, mobility, and other activities for living independently, such as shopping, cooking, driving, or accessing public transportation are all assessed. Barriers in the home, school, work, and community environments are identified. The need for adaptive equipment is assessed. The occupational therapist develops a treatment plan using clinical decision making from the patient analysis, assessment data, comorbidities, and possible treatment options. During a re-evaluation, an interim history is taken; the patient's response to treatment is evaluated; and the plan of care is revised based on the patient's response to treatment, functional and medical status, and any changes in condition or environment that affect future interventions or goals.
11% higher than market
Occupational therapy evaluation (typically 45 minutes) [HCPCS 97166]
Occupational therapy evaluation (typically 45 minutes) [HCPCS 97166]
An occupational therapy evaluation or re-evaluation is performed. Occupational therapy assists the patient in developing or regaining skills that allow independent functioning and enhance health and personal well-being. A patient history is taken that includes an occupational profile and medical and therapy history with review of records as well as an extensive review of physical, cognitive, or psychosocial elements related to current performance of daily activities. The occupational therapist evaluates the patient's physical functioning, mental, and/or neurobehavioral impairment and performs tests to identify functional limitations or performance deficits. Physical functioning is evaluated, including an evaluation of any musculoskeletal conditions that may impair function. The ability to perform basic activities of daily living such as dressing, bathing, mobility, and other activities for living independently, such as shopping, cooking, driving, or accessing public transportation are all assessed. Barriers in the home, school, work, and community environments are identified. The need for adaptive equipment is assessed. The occupational therapist develops a treatment plan using clinical decision making from the patient analysis, assessment data, comorbidities, and possible treatment options. During a re-evaluation, an interim history is taken; the patient's response to treatment is evaluated; and the plan of care is revised based on the patient's response to treatment, functional and medical status, and any changes in condition or environment that affect future interventions or goals.
16% lower than market
Occupational therapy evaluation with established plan of care (typically 60 minutes) [HCPCS 97167]
Occupational therapy evaluation with established plan of care (typically 60 minutes) [HCPCS 97167]
An occupational therapy evaluation or re-evaluation is performed. Occupational therapy assists the patient in developing or regaining skills that allow independent functioning and enhance health and personal well-being. A patient history is taken that includes an occupational profile and medical and therapy history with review of records as well as an extensive review of physical, cognitive, or psychosocial elements related to current performance of daily activities. The occupational therapist evaluates the patient's physical functioning, mental, and/or neurobehavioral impairment and performs tests to identify functional limitations or performance deficits. Physical functioning is evaluated, including an evaluation of any musculoskeletal conditions that may impair function. The ability to perform basic activities of daily living such as dressing, bathing, mobility, and other activities for living independently, such as shopping, cooking, driving, or accessing public transportation are all assessed. Barriers in the home, school, work, and community environments are identified. The need for adaptive equipment is assessed. The occupational therapist develops a treatment plan using clinical decision making from the patient analysis, assessment data, comorbidities, and possible treatment options. During a re-evaluation, an interim history is taken; the patient's response to treatment is evaluated; and the plan of care is revised based on the patient's response to treatment, functional and medical status, and any changes in condition or environment that affect future interventions or goals.
20% lower than market
Physcial therapy exercise of walking training to 1 or more areas (each 15 minutes) [HCPCS 97116]
Physcial therapy exercise of walking training to 1 or more areas (each 15 minutes) [HCPCS 97116]
Gait training is a therapeutic procedure that observes and educates an individual in the manner of walking including the rhythm, cadence, step, stride, and speed. The objective of gait training is to strengthen muscles and joints, improve balance and posture, and develop muscle memory. As the lower extremities are retrained for repetitive motion, the body also benefits from the exercise with increased endurance, improved heart/lung function, and reduced or improved osteoporosis. Gait training is an appropriate therapeutic procedure following brain and/or spinal cord injury, stroke, fracture of the pelvis and/or lower extremity, joint injury or replacement of the knee, hip, or ankle, amputation, and for certain musculoskeletal and/or neurological diseases. A treadmill fitted with a safety harness is initially used to ensure safe walking. As the patient gains strength and balance, step training and stair climbing is added to the treatment modality.
6% lower than market
Physical therapy evaluation (typically 20 minutes) [HCPCS 97161]
Physical therapy evaluation (typically 20 minutes) [HCPCS 97161]
A physical therapy evaluation or re-evaluation is performed. The physical therapist takes a history of the current complaint including onset of symptoms, comorbidities, changes since the onset, treatment received for the symptoms or condition, medications prescribed for it, and any other medications the patient is taking. A physical examination of body systems is done to assess physical structure and function, any activities or movements that exacerbate the symptoms, limit activity, or restrict participation in movement, as well as anything that helps to relieve the symptoms. The evaluation may involve provocative maneuvers or positions that increase symptoms; tests for joint flexibility and muscle strength; assessments of general mobility, posture, and core strength; evaluation of muscle tone; and tests for restrictions of movement caused by myofascial disorders. Following the history and physical, the therapist determines the patient's clinical presentation characteristics, provides a detailed explanation of the condition, identifies physical therapy treatment options, and explains how often and how long physical therapy modalities should be applied. The physical therapist will then develop a plan of care with clinical decision making based on patient assessment and/or measurable functional outcome. The plan of care may include both physical therapy in the clinic and exercises or changes in the home environment. Upon re-evaluation, the established care plan is reviewed and an interim history is taken requiring the use of standardized tests and measures. The patient's response to treatment is evaluated and the plan of care is revised based on the patient's measurable response.
Approximately equal to market
Physical therapy evaluation (typically 30 minutes) [HCPCS 97162]
Physical therapy evaluation (typically 30 minutes) [HCPCS 97162]
A physical therapy evaluation or re-evaluation is performed. The physical therapist takes a history of the current complaint including onset of symptoms, comorbidities, changes since the onset, treatment received for the symptoms or condition, medications prescribed for it, and any other medications the patient is taking. A physical examination of body systems is done to assess physical structure and function, any activities or movements that exacerbate the symptoms, limit activity, or restrict participation in movement, as well as anything that helps to relieve the symptoms. The evaluation may involve provocative maneuvers or positions that increase symptoms; tests for joint flexibility and muscle strength; assessments of general mobility, posture, and core strength; evaluation of muscle tone; and tests for restrictions of movement caused by myofascial disorders. Following the history and physical, the therapist determines the patient's clinical presentation characteristics, provides a detailed explanation of the condition, identifies physical therapy treatment options, and explains how often and how long physical therapy modalities should be applied. The physical therapist will then develop a plan of care with clinical decision making based on patient assessment and/or measurable functional outcome. The plan of care may include both physical therapy in the clinic and exercises or changes in the home environment. Upon re-evaluation, the established care plan is reviewed and an interim history is taken requiring the use of standardized tests and measures. The patient's response to treatment is evaluated and the plan of care is revised based on the patient's measurable response.
9% lower than market
Physical therapy evaluation (typically 45 minutes) [HCPCS 97163]
Physical therapy evaluation (typically 45 minutes) [HCPCS 97163]
A physical therapy evaluation or re-evaluation is performed. The physical therapist takes a history of the current complaint including onset of symptoms, comorbidities, changes since the onset, treatment received for the symptoms or condition, medications prescribed for it, and any other medications the patient is taking. A physical examination of body systems is done to assess physical structure and function, any activities or movements that exacerbate the symptoms, limit activity, or restrict participation in movement, as well as anything that helps to relieve the symptoms. The evaluation may involve provocative maneuvers or positions that increase symptoms; tests for joint flexibility and muscle strength; assessments of general mobility, posture, and core strength; evaluation of muscle tone; and tests for restrictions of movement caused by myofascial disorders. Following the history and physical, the therapist determines the patient's clinical presentation characteristics, provides a detailed explanation of the condition, identifies physical therapy treatment options, and explains how often and how long physical therapy modalities should be applied. The physical therapist will then develop a plan of care with clinical decision making based on patient assessment and/or measurable functional outcome. The plan of care may include both physical therapy in the clinic and exercises or changes in the home environment. Upon re-evaluation, the established care plan is reviewed and an interim history is taken requiring the use of standardized tests and measures. The patient's response to treatment is evaluated and the plan of care is revised based on the patient's measurable response.
17% lower than market
Physical therapy procedure to re-educate brain-to-nerve-to-muscle function (each 15 minutes) [HCPCS 97112]
Physical therapy procedure to re-educate brain-to-nerve-to-muscle function (each 15 minutes) [HCPCS 97112]
Therapeutic procedures for neuromuscular reeducation are used to develop conscious control of a single muscle or muscle group and heighten the awareness of the body's position in space, especially the position of the extremities when sitting or standing. Neuromuscular reeducation is employed during the recovery or regeneration stage following severe injury or trauma, cerebral vascular accident, or systemic neurological disease. The goal of therapy is improved range of motion (ROM), balance, coordination, posture, and spatial awareness. Techniques may include proprioceptive neuromuscular facilitation which uses diagonal contract-relax patterns of skeletal muscles to stimulate receptors in the joints that communicate body position to the brain via motor and sensory nerves. Feldenkrais is a method which observes the patient's habitual movement patterns and teaches new patterns based on efficient active or passive repetitive conditioning. Additional techniques that may be useful for neuromuscular reeducation are Bobath concept, which promotes motor learning and efficient motor control, and biomechanical ankle platform system (BAPS) boards.
40% lower than market
Physical therapy techniques to 1 or more regions (each 15 minutes) [HCPCS 97140]
Physical therapy techniques to 1 or more regions (each 15 minutes) [HCPCS 97140]
Manual therapies are skilled, specific, hands-on techniques usually performed by physical therapists, occupational therapists, chiropractors, osteopaths, and/or physiatrists to diagnose and treat soft tissue and joint problems. The goal of manual therapy is to modulate pain and induce relaxation, increase range of motion (ROM), facilitate movement, function, and stability, decrease inflammation, and improve muscle tone and extensibility. Tissue mobilization involves slow, controlled myofascial stretching using deep pressure to break up fibrous muscle tissue and/or connective tissue adhesions. Manipulation is a more forceful stretching of the myofascial tissue that takes the joint just beyond its restricted barrier. Manual lymphatic drainage is a type of light massage employed to reduce swelling by gentle movement of the skin in the direction of lymphatic flow. Manual traction involves the controlled counterforce of the therapist to induce asymptomatic strain by gently stretching muscle and/or connective tissue.
13% lower than market
Speech, language, voice, communication, and/or hearing processing disorder treatment [HCPCS 92507]
Speech, language, voice, communication, and/or hearing processing disorder treatment [HCPCS 92507]
A speech-language pathologist treats a speech, language, voice, communication, and/or auditory processing disorder. Using the information obtained from a separately reportable screening and in-depth evaluation of a speech or language disorder, the clinician develops an individualized treatment plan for the patient. The clinician defines specific treatment goals and sets baseline measures with which to assess the patient's progress. These goals are continuously monitored and fine-tuned throughout the treatment period. Once the goals and baseline measures have been established the clinician uses a number of intervention activities to correct the specific speech or language disorder identified. These can include games, stories, rhymes, drills, and other tasks. If the patient has a speech disorder, the clinician may demonstrate the sounds and have the patient copy the way the clinician moves the lips, mouth, and tongue to make the right sound. A mirror may be used so that the patient can practice making the sound while observing himself or herself in the mirror. Treatment of a language disorder might include help with grammar. If the patient is having difficulty with auditory processing, a game like Simon Says might be used to help improve understanding of verbal instructions.
18% higher than market
Swallowing and/or oral feeding function treatment [HCPCS 92526]
Swallowing and/or oral feeding function treatment [HCPCS 92526]
Swallowing dysfunction and/or oral function are treated in an individual with difficulty passing food or liquid from the mouth or throat into the stomach. A swallowing or oral function disorder can occur in any age group or at any point in the swallowing process as food or liquid passes from the mouth, through the pharynx and esophagus, into the stomach. Swallowing disorders are common in individuals with degenerative neurological disorders such as cerebral palsy, amyotrophic lateral sclerosis (ALS), postpolio syndrome, myasthenia gravis, multiple sclerosis, and Parkinson's disease. A swallowing disorder may also result from neurological damage such as a stroke or head or spinal cord injury, or from a congenital or acquired deformity of the mouth, pharynx, esophagus, or stomach. Medical treatment is provided for a patient with a swallowing or oral function disorder. The diet is modified. Swallowing posture is assessed and modified as needed. Swallowing technique is modified to strengthen oropharyngeal muscle groups and improve the mechanics of swallowing so that food and liquid can pass into the esophagus and then into the stomach without aspiration into the lungs.
10% lower than market
Swallowing function evaluation [HCPCS 92610]
Swallowing function evaluation [HCPCS 92610]
An evaluation of the oral and pharyngeal phase of the swallowing function is performed in a patient who is suspected of having oropharyngeal dysphagia. The initial evaluation is typically performed by a dysphagia specialist, usually a speech-language pathologist. This evaluation is performed to determine whether more extensive studies are warranted. Swallowing function is divided into oral, pharyngeal, and esophageal phases. The oral and pharyngeal phases are made up of oral preparation for solid foods (not required for liquids or pureed foods), oral transfer, and initiation of the swallow. Both oral and pharyngeal movements are necessary in preparing, transferring, and swallowing food. The patient is given both solids and liquids to swallow. During oral preparation of solid food the ability of the tongue to move the food from side-to-side so that the solid can be chewed and prepared for swallowing is evaluated. Once the solid food is prepared and transferred to the back of the throat, the swallowing movements are evaluated. Propelling solids or liquids requires a complex set of movements including retraction of the base of the tongue, elevation of the hyolarynx, closure of the velopharyngeus, contraction of the pharynx, opening of the upper esophageal sphincter, and closure of the airway. The speech-language pathologist observes the patient to determine whether solids and liquids are being prepared, transferred, and propelled from the pharynx into the esophagus. A written report of findings is provided.
9% lower than market
Training activities for home and self-care management (each 15 minutes) [HCPCS 97535]
Training activities for home and self-care management (each 15 minutes) [HCPCS 97535]
Self-care/home managemeThe patient receives one-on-one training to improve the ability to care for himself/herself and maintain independence. This may include training in activities of daily living (ADL), such as bed mobility, transfers, dressing, grooming, eating, bathing and toileting. The patient is given instruction on compensatory measures that can be taken to overcome any physical, mental or emotional disabilities. The patient receives training in how to adapt meal preparation to his/her specific needs and how to perform activities safely. The patient may also receive instruction in the use of assistive technology devices and adaptive equipment which includes any item used to improve the functional capability of the patient in the home and with ADL. This code is reported for each 15 minutes of one-on-one self-care/home management training designed to meet the specific needs of the patient.nt training, which includes instructions in the use of any assisting equipment.
19% lower than market
Harbor Regional Health Patient Information Price List
OUTPATIENT X-RAY AND RADIOLOGICAL
OUTPATIENT X-RAY AND RADIOLOGICAL
Description
Variance
Abdominal and pelvic vessels CTA scan with contrast [HCPCS 74174]
Abdominal and pelvic vessels CTA scan with contrast [HCPCS 74174]
Computed tomographic angiography (CTA) provides images of the blood vessels using a combination of computed tomography (CT) and angiography with contrast material. When angiography is performed using CT, multiple images are obtained and processed on a computer to create detailed, two-dimensional, cross-sectional views of the blood vessels. These images are then displayed on a computer monitor. The patient is positioned on the CT table. An intravenous line is inserted into a blood vessel, usually in the arm or hand. Non-contrast images of the abdomen and pelvis are obtained as needed. A small dose of contrast is injected and test images are obtained to verify correct positioning. The CTA of the abdomen and pelvis is then performed. Contrast is injected at a controlled rate and the CT table moves through the CT machine as the scanning is performed. After completion of the CTA, the radiologist reviews and interprets the CTA images of the blood vessels of the abdomen and pelvis.
63% lower than market
Abdominal aorta and both leg arteries CTA scan with contrast [HCPCS 75635]
Abdominal aorta and both leg arteries CTA scan with contrast [HCPCS 75635]
A computed tomographic angiography (CTA) of the abdominal aorta with bilateral iliofemoral lower extremity run-off is performed with contrast material including image postprocessing. Noncontrast images may also be obtained and are included when performed. CTA provides images of the blood vessels using a combination of computed tomography (CT) and angiography with contrast material. When angiography is performed using CT, multiple images are obtained and processed on a computer to create detailed, two-dimensional, cross-sectional views of the blood vessels. These images are then displayed on a computer monitor. The patient is positioned on the CT table. An intravenous line is inserted into a blood vessel, usually in the arm or hand. Non-contrast images may be obtained. A small dose of contrast is injected and test images are obtained to verify correct positioning. The CTA is then performed. Contrast is injected at a controlled rate and the CT table moves through the CT machine as the scanning is performed. After completion of the CTA, the radiologist reviews and interprets the CTA images of the abdominal aorta with bilateral iliofemoral lower extremity runoff.
10% higher than market
Abdominal aorta ultrasound for screening of abdominal aortic aneurysm [HCPCS 76706]
Abdominal aorta ultrasound for screening of abdominal aortic aneurysm [HCPCS 76706]
5% lower than market
Abdominal x-ray (single view) [HCPCS 74018]
Abdominal x-ray (single view) [HCPCS 74018]
A radiologic examination of the abdomen images the internal organs, soft tissue (muscle, fat), and supporting skeleton. X-ray imaging uses indirect ionizing radiation to take pictures of non-uniform material, such as human tissue, because of its different density and composition, which allows some of the x-rays to be absorbed and some to pass through and be captured. This produces a 2D image of the structures. The radiographs may be taken to look for size, shape, and position of organs, pattern of air (bowel gas), obstruction, foreign objects, and calcification in the gallbladder, urinary tract, and aorta. A radiologic examination of the abdomen may be ordered to diagnose abdominal distention and pain, vomiting, diarrhea or constipation, and traumatic injury; it may also be obtained as a screening exam or scout film prior to other imagining procedures. Common views of the abdomen include front to back anteroposterior (AP) with the patient lying supine or standing erect, back to front posteroanterior (PA) with the patient lying prone, lateral with the patient lying on the side, lateral decubitus anteroposterior (side lying, front to back view), lateral dorsal decubitus (lying supine, side view), oblique (anterior or posterior rotation), and coned (small collimated) views which may be used to localize and differentiate lesions, calcifications, or herniations.
5% lower than market
Abdominal x-ray, complete study including 2 or more views of abdomen and single view of chest [HCPCS 74022]
Abdominal x-ray, complete study including 2 or more views of abdomen and single view of chest [HCPCS 74022]
A radiologic examination of the abdomen images the internal organs, soft tissue (muscle, fat), and supporting skeleton. X-ray imaging uses indirect ionizing radiation to take pictures of non-uniform material, such as human tissue, because of its different density and composition, which allows some of the x-rays to be absorbed and some to pass through and be captured. This produces a 2D image of the structures. The radiographs may be taken to look for size, shape, and position of organs, pattern of air (bowel gas), obstruction, foreign objects, and calcification in the gallbladder, urinary tract, and aorta. A radiologic examination of the abdomen may be ordered to diagnose abdominal distention and pain, vomiting, diarrhea or constipation, and traumatic injury; it may also be obtained as a screening exam or scout film prior to other imagining procedures.
2% higher than market
Ankle x-ray (minimum of 3 views) [HCPCS 73610]
Ankle x-ray (minimum of 3 views) [HCPCS 73610]
A radiologic examination of the ankle images the bones of the distal lower extremities including the tibia, fibula, and talus. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures. The radiographs may be taken to look for the cause of pain, limping, or swelling, or conditions such as fractures, dislocations, deformities, degenerative disease, osteomyelitis, arthritis, foreign body, and cysts or tumors. Ankle x-rays may also be used to determine whether there is satisfactory alignment of lower extremity bones following fracture treatment. Standard views of the ankle include front to back anteroposterior (AP), lateral (side), oblique (semi-prone position with body and leg partially rotated), and stress study with traction placed on the joint manually.
9% lower than market
Arm x-ray of forearm (2 views) [HCPCS 73090]
Arm x-ray of forearm (2 views) [HCPCS 73090]
A radiologic examination of the forearm is done. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures. Frontal views, or back to front (PA) views and lateral views are necessary to show the radius and ulna and assess the extent and direction of injury. Since the radius and ulna are anatomically connected at both ends of the bones with ligaments, the two bones function in a manner that makes the forearm considered as a single unit when assessing injury. The two standard views taken for x-ray examination of the forearm include the anteroposterior (AP) view, and the lateral view.
1% higher than market
Arm x-ray of upper arm (minimum of 2 views) [HCPCS 73060]
Arm x-ray of upper arm (minimum of 2 views) [HCPCS 73060]
A radiologic examination of the humerus is done with a minimum of 2 views taken. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures. The surgical neck of the humerus is the most common site of fracture. Shaft fractures are often associated with some kind of pathological lesion. X-rays of the humerus can be taken to detect deformities or lesions in the upper arm, such as cysts, tumors, late stage infection, or other diseases as well as a broken bone. The standard views of the humerus include the front to back anteroposterior view and the side, or lateral view.
Approximately equal to market
Arms or legs veins ultrasound with assessment of compression and functional maneuvers (complete, both arms or legs) [HCPCS 93970]
Arms or legs veins ultrasound with assessment of compression and functional maneuvers (complete, both arms or legs) [HCPCS 93970]
A vascular ultrasound study is performed to evaluate veins in the extremities. A duplex scan uses both B-mode and Doppler studies. A clear gel is placed on the skin of the extremity over the region to be studied. A B-mode transducer is placed on the skin and real-time images of the veins are obtained. A Doppler probe within the B-mode transducer provides information on the pattern and direction of blood flow in the veins. The B-mode transducer produces ultrasonic sound waves that move through the skin and bounce off the veins when the probe is moved over the region being studied. The Doppler probe produces sound waves that bounce off blood cells moving within the veins. The reflected sound waves are sent to an amplifier that makes the sound waves audible. The pitch of the sound waves changes if there is reduced blood flow, or ceases altogether if a vessel is completely obstructed. A computer converts the sound waves to images that are overlaid with colors to produce video images showing the speed and direction of blood flow as well as any obstruction. Spectral Doppler analysis is performed to provide information on anatomy and hemodynamic function. The duplex scan may include a baseline evaluation followed by additional scans obtained with compression or using other maneuvers that alter blood flow. The physician reviews the duplex scan and provides a written interpretation of findings.
7% lower than market
Bone density measurement of the axial skeleton (hips, pelvis, spine) [HCPCS 77080]
Bone density measurement of the axial skeleton (hips, pelvis, spine) [HCPCS 77080]
These codes report dual-energy x-ray absorptiometry (DXA) for bone density study. Measuring bone mass or bone mineral density (BMD) is done to diagnose for bone disease, evaluate bone disease progression, or monitor the results of treatment, particularly for osteoporosis, which puts a bone at higher risk of fracture. The radiation dose of DXA is around 1/30th of that in a standard chest x-ray. DXA involves aiming two x-ray beams of different energy levels at the bones in alternate pulses. Soft tissue absorption is subtracted out, and the BMD is determined by the bone's absorption of each beam in the projected area. The DXA scan measurement is then compared to a same sex standard of bone density at age 30, since the maximum BMD occurs at age 30 in both males and females. The difference between the measured BMD and the sex-matched, average 30-year-old standard is known as the T score. A T score between -1.0 and -2.4 diagnoses osteopenia, while a T score of -2.5 or less indicates osteoporosis.
39% lower than market
Breast ultrasound (one breast, limited) [HCPCS 76642]
Breast ultrasound (one breast, limited) [HCPCS 76642]
A real time ultrasound of the right or left breast is performed with image documentation, including the axillary area, when performed. Breast ultrasound is used to help diagnose breast abnormalities detected during a physical exam or on mammography. Ultrasound imaging can identify masses as solid or fluid-filled and can show additional structural features of the abnormal area and surrounding tissues. The patient is placed supine with the arm raised above the head on the side being examined. Acoustic coupling gel is applied to the breast and the transducer is pressed firmly against the skin of the breast. The transducer is then swept back and forth over the area of the abnormality and images are obtained. The ultrasonic wave pulses directed at the breast are imaged by recording the ultrasound echoes. Any abnormalities are evaluated to identify characteristics that might provide a definitive diagnosis. The physician reviews the ultrasound images of the breast and provides a written interpretation.
53% lower than market
Chest CT scan without contrast to examine injury, foreign bodies, or tumors [HCPCS 71250]
Chest CT scan without contrast to examine injury, foreign bodies, or tumors [HCPCS 71250]
Diagnostic computed tomography (CT) is done on the thorax. CT uses multiple, narrow x-ray beams aimed around a single rotational axis, taking a series of 2D images of the target structure from multiple angles. Contrast material is used to enhance the images. Computer software processes the data and reconstructs a 3D image. Thin, cross-sectional 2D and 3D slices are then produced of the targeted organ or area. The patient is placed inside the CT scanner on the table and images are obtained of the thorax to look for problems or disease in the lungs, heart, esophagus, soft tissue, or major blood vessels of the chest, such as the aorta. The physician reviews the images to look for suspected disease such as infection, lung cancer, pulmonary embolism, aneurysms, and metastatic cancer to the chest from other areas.
12% higher than market
Chest x-ray (2 views) [HCPCS 71046]
Chest x-ray (2 views) [HCPCS 71046]
A radiologic examination of the chest is performed. Chest radiographs (X-rays) provide images of the heart, lungs, bronchi, major blood vessels (aorta, vena cava, pulmonary vessels), and bones, (sternum, ribs, clavicle, scapula, spine). The most common views are frontal (also referred to as anteroposterior or AP), posteroanterior (PA), and lateral. To obtain a frontal view, the patient is positioned facing the x-ray machine. A PA view is obtained with the patient's back toward the x-ray machine. For a lateral view, the patient is positioned with side of the chest toward the machine. Other views that may be obtained include apical lordotic, oblique, and lateral decubitus. An apical lordotic image provides better visualization of the apical (top) regions of the lungs. The patient is positioned with the back arched so that the tops of the lungs can be x-rayed. Oblique views may be obtained to evaluate a pulmonary or mediastinal mass or opacity or to provide additional images of the heart and great vessels. There are four positions used for oblique views including right and left anterior oblique, and right and left posterior oblique. Anterior oblique views are obtained with the patient standing and the chest rotated 45 degrees. The arm closest to the x-ray cassette is flexed with the hand resting on the hip. The opposite arm is raised as high as possible. The part of the chest farthest away from the x-ray cassette is the area being studied. Posterior oblique views are typically obtained only when the patient is too ill to stand or lay prone for anterior oblique views. A lateral decubitus view is obtained with the patient lying on the side; the patient's head rests on one arm, and the other arm is raised over the head with the elbow bent. Images are recorded on hard copy film or stored electronically as digital images. The physician reviews the images, notes any abnormalities, and provides a written interpretation of the findings.
5% lower than market
Chest x-ray (single view) [HCPCS 71045]
Chest x-ray (single view) [HCPCS 71045]
A radiologic examination of the chest is performed. Chest radiographs (X-rays) provide images of the heart, lungs, bronchi, major blood vessels (aorta, vena cava, pulmonary vessels), and bones, (sternum, ribs, clavicle, scapula, spine). The most common views are frontal (also referred to as anteroposterior or AP), posteroanterior (PA), and lateral. To obtain a frontal view, the patient is positioned facing the x-ray machine. A PA view is obtained with the patient's back toward the x-ray machine. For a lateral view, the patient is positioned with side of the chest toward the machine. Other views that may be obtained include apical lordotic, oblique, and lateral decubitus. An apical lordotic image provides better visualization of the apical (top) regions of the lungs. The patient is positioned with the back arched so that the tops of the lungs can be x-rayed. Oblique views may be obtained to evaluate a pulmonary or mediastinal mass or opacity or to provide additional images of the heart and great vessels. There are four positions used for oblique views including right and left anterior oblique, and right and left posterior oblique. Anterior oblique views are obtained with the patient standing and the chest rotated 45 degrees. The arm closest to the x-ray cassette is flexed with the hand resting on the hip. The opposite arm is raised as high as possible. The part of the chest farthest away from the x-ray cassette is the area being studied. Posterior oblique views are typically obtained only when the patient is too ill to stand or lay prone for anterior oblique views. A lateral decubitus view is obtained with the patient lying on the side; the patient's head rests on one arm, and the other arm is raised over the head with the elbow bent. Images are recorded on hard copy film or stored electronically as digital images. The physician reviews the images, notes any abnormalities, and provides a written interpretation of the findings.
1% lower than market
Digital tomography of both breasts (screening exam) [HCPCS 77063]
Digital tomography of both breasts (screening exam) [HCPCS 77063]
Digital screening mammogram
30% lower than market
Elbow x-ray, complete study (minimum of 3 views) [HCPCS 73080]
Elbow x-ray, complete study (minimum of 3 views) [HCPCS 73080]
A radiologic examination of the elbow is done. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures. X-rays of the elbow are usually considered necessary to assess for fractures or dislocations when the normal range of motion for extension, flexion, supination, and pronation cannot be carried out. Most acute disruptions of the elbow joint can be diagnosed by conventional x-ray examination, with the minimum number of views including the front to back anteroposterior projection with the elbow in as full extension as possible, and the side, or lateral image taken in flexion. A complete series of images also includes an oblique view of the radial head-capitellar image to help diagnose suspected subtle fractures involving the radial head or in cases of acute pain and trauma. The patient needs to be able to hold the elbow in full extension for the front view and in 90 degree flexion for the oblique and lateral views as much as possible.
2% lower than market
Esophagus x-ray with barium swallow (single contrast material swallowed) [HCPCS 74220]
Esophagus x-ray with barium swallow (single contrast material swallowed) [HCPCS 74220]
Oral contrast material is swallowed and the passage of the contrast is observed fluoroscopically as it passes through the pharynx and/or esophagus. Once the lumen of the pharynx and/or esophagus is completely coated with contrast material, still radiographic images are obtained. The physician reviews the images, notes any abnormalities, and provides a written interpretation of the findings.
29% lower than market
Finger(s) x-ray (minimum of 2 views) [HCPCS 73140]
Finger(s) x-ray (minimum of 2 views) [HCPCS 73140]
A radiologic examination of the finger(s) is done with at least 2 different projections taken. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures. The radiographs may be taken to look for conditions such as fractures, interphalangeal (IP) joint dislocations, deformities, degenerative bone conditions, osteomyelitis, arthritis, foreign body, or tumors. The posteroanterior projection is taken with the palm down flat, fingers extended, and slightly apart to show the metacarpals, phalanges, and IP joints of the target finger(s). Anteroposterior views are taken with the back of the hand placed on the film and the x-ray beam going from palmar to dorsal direction. Lateral views are taken with the ulnar side of the hand on the film cassette and the fingers spread apart to avoid overlap, sometimes supported from underneath. Oblique views can be obtained with the hand placed palm down and the radial side rotated 45 degrees up away from the surface, with the fingers extended and spread apart.
3% higher than market
Guidance to access blood vessel by ultrasound [HCPCS 76937]
Guidance to access blood vessel by ultrasound [HCPCS 76937]
13% higher than market
Hand x-ray (minimum of 2 views) [HCPCS 73130]
Hand x-ray (minimum of 2 views) [HCPCS 73130]
A radiologic examination of the hand is done. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures. The radiographs may be taken to look for conditions such as fractures, dislocations, deformities, degenerative bone conditions, osteomyelitis, arthritis, foreign body, or tumors. Hand x-rays are also used to help determine the 'bone age' of children and assess whether any nutritional or metabolic disorders may be interfering with proper development. The posteroanterior projection is taken with the palm down flat and may show not only the metacarpals, phalanges, and interphalangeal joints, but the carpal bones, radius, and ulna as well. Lateral views may be taken with the hand placed upright, resting upon the ulnar side of the palm and little finger with the thumb on top, ideally with the fingers supported by a sponge and splayed to avoid overlap. Oblique views can be obtained with the hand placed palm down and rolled slightly to the outside with the fingertips still touching the film surface. The beam is angled perpendicular to the cassette for oblique projections and aimed at the middle finger metacarpophalangeal joint.
6% lower than market
Heart ultrasound including color-depicted blood flow rate, direction, and valve function [HCPCS 93306]
Heart ultrasound including color-depicted blood flow rate, direction, and valve function [HCPCS 93306]
The physician performs complete transthoracic real-time echocardiography with image documentation (2-D) including M-mode recording, if performed, with spectral Doppler and color flow Doppler echocardiography. Cardiac structure and dynamics are evaluated using a series of real-time tomographic images with multiple views recorded digitally or on videotape. Time-motion (M-mode) recordings are made as needed to allow dimensional measurement. Blood flow and velocity patterns within the heart, across valves and within the great vessels are evaluated by color flow Doppler. Normal blood flow patterns through these regions have a characteristic pattern defined by direction, velocity, duration, and timing throughout the cardiac cycle. Spectral Doppler by pulsed or continuous wave technique is used to evaluate antegrade flow through inflow and outflow tracts and cardiac valves. Multiple transducer positions or orientations may be required. The physician reviews the echocardiography images and orders additional images as needed to allow evaluation of any abnormalities. Digital or videotaped images are then reviewed by the physician. Abnormalities of cardiac structure or dynamics are noted. The extent of the abnormalities is evaluated and quantified. Any previous cardiac studies are compared to the current study and any quantitative or qualitative changes are identified. The physician provides an interpretation of the echocardiography with a written report of findings.
11% higher than market
Imaging for swallowing function evaluation with contrast [HCPCS 74230]
Imaging for swallowing function evaluation with contrast [HCPCS 74230]
A radiologic study with cineradiography/videoradiography may be performed to assess swallowing function in patients with dysphagia. A swallowing function study (modified barium swallow, MBS) may be indicated for patients with a history of stroke or other central nervous system (CNS) disorders, surgery or radiation to the head/neck, neuromuscular or rheumatologic disease, generalized debilitation and head/neck/throat injury including peripheral nerve injury. The patient is seated upright or semi-reclining with the fluoroscopy machine focused on the head and neck. Food and liquids of various texture and quantity are mixed or soaked in contrast medium (barium) and administered to the patient. A fluoroscopic recording is made of the food or fluid in the oral cavity, larynx, pharynx, and upper esophagus to document mastication and tongue mobility, elevation and retraction of the velum, tongue base retraction and movement of the hyoid bone and larynx, closure of the larynx, contraction of the pharynx, and the duration and extent of pharyngoesophageal segment opening. Observation and recording is made of any penetration or aspiration of food and fluid into the upper airways. The measurement of muscle sensation and strength may be inferred or calculated directly from the information obtained during the study.
7% lower than market
Imaging of abdomen by MRI without contrast, followed by contrast [HCPCS 74183]
Imaging of abdomen by MRI without contrast, followed by contrast [HCPCS 74183]
Magnetic resonance imaging is done on the abdomen. Magnetic resonance is a noninvasive, non-radiating imaging technique that uses the magnetic properties of hydrogen atoms in the body. The patient is placed on a motorized table within a large MRI tunnel scanner that contains the magnet. The powerful magnetic field forces the hydrogen atoms to line up. Radiowaves are then transmitted within the strong magnetic field. Protons in the nuclei of different types of tissues emit a specific radiofrequency signal that bounces back to the computer, which processes the signals and converts the data into tomographic, 3D images with very high resolution. The patient is placed on a motorized table within a large MRI tunnel scanner that contains the magnet. Small coils that help transmit and receive the radiowaves may be placed around the abdomen. MRI is often done for trauma and suspected internal injury, and unexplained abdominal pain, swelling, and fever. MRI scans provide clear images of areas that may be difficult to see on CT. The physician reviews the images to look for information that may correlate to the patient's signs or symptoms, such as the location of tumors, abscesses, or masses; the presence of kidney stones, hernias, appendicitis or other infections, and internal injury.
34% lower than market
Imaging of arm joint by MRI without contrast [HCPCS 73221]
Imaging of arm joint by MRI without contrast [HCPCS 73221]
Magnetic resonance imaging is done on a joint of the upper or lower arm. Magnetic resonance is a noninvasive, non-radiating imaging technique that uses the magnetic properties of hydrogen atoms in the body. The patient is placed on a motorized table within a large MRI tunnel scanner that contains the magnet. The powerful magnetic field forces the hydrogen atoms to line up. Radiowaves are then transmitted within the strong magnetic field. Protons in the nuclei of different types of tissues emit a specific radiofrequency signal that bounces back to the computer, which processes the signals and converts the data into tomographic, 3D images with very high resolution. The patient is placed on a motorized table within a large MRI tunnel scanner that contains the magnet. Small coils that help transmit and receive the radiowaves may be placed around the joint. MRI scans on joints of the upper extremity are often done for injury, trauma, unexplained pain, redness, or swelling, and freezing of a joint with loss of motion. MRI scans provide clear images of areas that may be difficult to see on CT.
38% lower than market
Imaging of brain by MRI without contrast [HCPCS 70551]
Imaging of brain by MRI without contrast [HCPCS 70551]
Magnetic resonance imaging is done on the brain. MRI is a noninvasive, non-radiating imaging technique that uses the magnetic properties of hydrogen atoms in the body. The patient is placed on a motorized table within a large MRI tunnel scanner that contains the magnet. The powerful magnetic field forces the hydrogen atoms to line up. Radiowaves are then transmitted within the strong magnetic field. Protons in the nuclei of different types of tissues emit a specific radiofrequency signal that bounces back to the computer, which processes the signals and converts the data into tomographic, 3D images with very high resolution. MRI of the brain provides reliable information for diagnosing the presence, location, and extent of tumors, cysts, or other masses; swelling and infection; vascular disorders or malformations, such as aneurysms and intracranial hemorrhage; disease of the pituitary gland; stroke; developmental and structural anomalies of the brain; hydrocephalus; and chronic conditions and diseases affecting the central nervous system such as headaches and multiple sclerosis.
39% lower than market
Imaging of head blood vessels by MRA without contrast [HCPCS 70544]
Imaging of head blood vessels by MRA without contrast [HCPCS 70544]
Magnetic resonance angiography (MRA) is performed on the head without contrast materials, with contrast materials, and without contrast materials followed by contrast materials. MRA is a noninvasive radiology procedure used to evaluate arterial and venous vessels for conditions such as atherosclerotic stenosis, arterial dissection, acute thrombosis, aneurysms or pseudo-aneurysms, vascular loops, vascular malformations/tumors, or arterial causes of pulsatile tinnitus. MRA may be performed following vascular surgery on the intracranial vessels to assess vascular status. MRA uses a magnetic field and pulses of radiowave energy to provide images of the blood vessels. Multiple images, 1-2 mm in thickness, are obtained and then processed using an array algorithm to produce maximum intensity projections (MIPs). MIPs are similar to subtraction angiograms. Areas of interest are identified by the radiologist and coned down to produce detailed views of the arteries. This post-processing of the images is performed by a technologist. The MIPs are reviewed by the radiologist along with the initial MRA images. The radiologist provides a written interpretation of findings.
46% lower than market
Imaging of heart vessels with SPECT tomography and drugs or exercise (multiple studies) [HCPCS 78452]
Imaging of heart vessels with SPECT tomography and drugs or exercise (multiple studies) [HCPCS 78452]
Myocardial perfusion imaging is a nuclear medicine procedure used to evaluate the heart muscle and blood flow to the heart. An intravenous line is inserted into a vein in the hand or arm. ECG leads are placed and a blood pressure cuff is placed on the arm. The patient lies flat on a table in the procedure room for myocardial perfusion imaging performed at rest. For a stress study, the patient is either on a treadmill or bike or an injection of a pharmacologic agent is administered to stress the heart. A radionuclide, also called a tracer, is injected into the intravenous line and allowed to circulate. The radionuclide localizes in healthy heart tissue. Ischemic heart tissue does not absorb the radionuclide. Images of the heart and great vessels are obtained using single photon emission computed tomography (SPECT). When SPECT images are obtained, the scanner rotates around the body to obtain images in multiple planes. The physician evaluates heart wall motion to determine how effective the heart muscle is in pumping blood through the heart and to the peripheral vascular system. Ejection fraction, which is the percentage of blood pumped out of the heart to the peripheral vascular system, is measured using either a first pass or gated technique. In a first pass technique, images are obtained as the blood circulates through the heart during the first pass of the radionuclide. In a gated technique, a series of images are obtained between heart beats. Using electrical signals from the heart, the camera captures a series of images as the heart rests, creating very sharp, high resolution images. Additional images are obtained as needed. The physician reviews the images, calculates the ejection fraction and quantifies other parameters of heart function based on the distribution of the radionuclide. The physician then provides a written report of findings.
12% lower than market
Imaging of heart vessels with SPECT tomography and drugs or exercise (single study) [HCPCS 78451]
Imaging of heart vessels with SPECT tomography and drugs or exercise (single study) [HCPCS 78451]
Myocardial perfusion imaging is a nuclear medicine procedure used to evaluate the heart muscle and blood flow to the heart. An intravenous line is inserted into a vein in the hand or arm. ECG leads are placed and a blood pressure cuff is placed on the arm. The patient lies flat on a table in the procedure room for myocardial perfusion imaging performed at rest. For a stress study, the patient is either on a treadmill or bike or an injection of a pharmacologic agent is administered to stress the heart. A radionuclide, also called a tracer, is injected into the intravenous line and allowed to circulate. The radionuclide localizes in healthy heart tissue. Ischemic heart tissue does not absorb the radionuclide. Images of the heart and great vessels are obtained using single photon emission computed tomography (SPECT). When SPECT images are obtained, the scanner rotates around the body to obtain images in multiple planes. The physician evaluates heart wall motion to determine how effective the heart muscle is in pumping blood through the heart and to the peripheral vascular system. Ejection fraction, which is the percentage of blood pumped out of the heart to the peripheral vascular system, is measured using either a first pass or gated technique. In a first pass technique, images are obtained as the blood circulates through the heart during the first pass of the radionuclide. In a gated technique, a series of images are obtained between heart beats. Using electrical signals from the heart, the camera captures a series of images as the heart rests, creating very sharp, high resolution images. Additional images are obtained as needed. The physician reviews the images, calculates the ejection fraction and quantifies other parameters of heart function based on the distribution of the radionuclide. The physician then provides a written report of findings.
46% lower than market
Imaging of middle spinal canal by MRI without contrast [HCPCS 72146]
Imaging of middle spinal canal by MRI without contrast [HCPCS 72146]
Magnetic resonance imaging (MRI) is done on the thoracic spinal canal and contents. MRI is a noninvasive, non-radiating imaging technique that uses the magnetic properties of nuclei within hydrogen atoms of the body. The powerful magnetic field forces the hydrogen atoms to line up. Radiowaves are then transmitted within the strong magnetic field. Protons in the nuclei of different types of tissues emit a specific radiofrequency signal that bounces back to the computer, which records the images. The computer processes the signals and converts the data into tomographic, 3D, sectional images in slices with very high resolution. The patient is placed on a motorized table within a large MRI tunnel scanner that contains the magnet. MRI scans of the spine are often done when conservative treatment of back/neck pain is unsuccessful and more aggressive treatments are considered or following surgery.
39% lower than market
Imaging of upper spinal canal by MRI without contrast [HCPCS 72141]
Imaging of upper spinal canal by MRI without contrast [HCPCS 72141]
Magnetic resonance imaging (MRI) is done on the cervical spinal canal and contents. MRI is a noninvasive, non-radiating imaging technique that uses the magnetic properties of nuclei within hydrogen atoms of the body. The powerful magnetic field forces the hydrogen atoms to line up. Radiowaves are then transmitted within the strong magnetic field. Protons in the nuclei of different types of tissues emit a specific radiofrequency signal that bounces back to the computer, which records the images. The computer processes the signals and converts the data into tomographic, 3D, sectional images in slices with very high resolution. The patient is placed on a motorized table within a large MRI tunnel scanner that contains the magnet. MRI scans of the spine are often done when conservative treatment of back/neck pain is unsuccessful and more aggressive treatments are considered or following surgery.
35% lower than market
Knee x-ray (1 or 2 views) [HCPCS 73560]
Knee x-ray (1 or 2 views) [HCPCS 73560]
A radiologic examination of the knee images the femur, tibia, fibula, patella, and soft tissue. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures. The radiographs may be taken to look for the cause of pain, limping, or swelling, or conditions such as fractures, dislocations, deformities, degenerative disease, osteomyelitis, arthritis, foreign body, and cysts or tumors. Knee x-rays may also be used to determine whether there is satisfactory alignment of lower extremity bones following fracture treatment. Standard views of the knee include front to back anteroposterior (AP), lateral (side), and back to front posteroanterior (PA) with variations in the flexion of the joint, and weight bearing and non-weight bearing postures.
7% lower than market
Knee x-ray (3 views) [HCPCS 73562]
Knee x-ray (3 views) [HCPCS 73562]
A radiologic examination of the knee images the femur, tibia, fibula, patella, and soft tissue. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures. The radiographs may be taken to look for the cause of pain, limping, or swelling, or conditions such as fractures, dislocations, deformities, degenerative disease, osteomyelitis, arthritis, foreign body, and cysts or tumors. Knee x-rays may also be used to determine whether there is satisfactory alignment of lower extremity bones following fracture treatment. Standard views of the knee include front to back anteroposterior (AP), lateral (side), and back to front posteroanterior (PA) with variations in the flexion of the joint, and weight bearing and non-weight bearing postures.
9% lower than market
Leg CT scan without contrast for injury, foreign bodies, or tumors [HCPCS 73700]
Leg CT scan without contrast for injury, foreign bodies, or tumors [HCPCS 73700]
Diagnostic computed tomography (CT) is done on the lower extremity to provide detailed visualization of the tissues and bone structure of the leg. CT uses multiple, narrow x-ray beams aimed around a single rotational axis, taking a series of 2D images of the target structure from multiple angles. Contrast material is used to enhance the images. Computer software processes the data and produces several images of thin, cross-sectional 2D slices of the targeted organ or area. Three-dimensional models of the leg can be created by stacking multiple, individual 2D slices together. The patient is placed inside the CT scanner on the table and images are obtained of the lower extremity.
1% lower than market
Lower leg x-ray (2 views) [HCPCS 73590]
Lower leg x-ray (2 views) [HCPCS 73590]
A radiologic examination of the tibia and fibula images the bones of the distal lower extremities and may include the knee and ankle joints. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures. The radiographs may be taken to look for the cause of pain, limping, or swelling, or conditions such as fractures, dislocations, deformities, degenerative disease, osteomyelitis, arthritis, foreign body, and cysts or tumors. Tibia and fibula x-rays may also be used to determine whether there is satisfactory alignment of lower extremity bones following fracture treatment. Standard views of the tibia and fibula include front to back anteroposterior (AP) and lateral (side).
5% lower than market
Neck CT scan of the soft tissue of the neck with contrast to examine injury, foreign bodies, or tumors [HCPCS 70491]
Neck CT scan of the soft tissue of the neck with contrast to examine injury, foreign bodies, or tumors [HCPCS 70491]
Computerized tomography, also referred to as a CT scan, uses special x-ray equipment and computer technology to produce multiple cross-sectional images of the region being studied. In a CT scan of the soft tissues of the neck, the patient is positioned on the CT examination table. An initial pass is made through the CT scanner to determine the starting position of the scans, after which the CT scan is performed. As the table moves slowly through the scanner, numerous x-ray beams and electronic x-ray detectors rotate around the body region being examined. The amount of radiation being absorbed is measured. As the beams and detectors rotate around the body, the table is moved through the scanner. A computer program processes the data and renders the data in two-dimensional cross-sectional images of the body region being examined. This data is displayed on a monitor. The physician reviews the data as it is being obtained and may request additional sections to provide more detail of areas of interest.
18% higher than market
Rib cage x-ray of ribs on one side of body (2 views) [HCPCS 71100]
Rib cage x-ray of ribs on one side of body (2 views) [HCPCS 71100]
Rib radiographs (x-rays) are typically obtained following trauma to the rib cage to determine if fractures or other internal injuries are present. The most common views of the ribs are anteroposterior (AP) (frontal) and oblique. There are four positions used for oblique views: right anterior oblique, left anterior oblique, right posterior oblique, and left posterior oblique. Anterior oblique views are obtained with the patient standing and the chest rotated 45 degrees. The arm closest to the x-ray cassette is flexed with the hand resting on the hip. The opposite arm is raised as high as possible. The part of the chest farthest away from the x-ray cassette is the area that is being studied. Posterior oblique views are typically obtained only when the patient is too ill to stand or lay prone for anterior oblique views.
5% lower than market
Shoulder x-ray, complete study (minimum of 2 views) [HCPCS 73030]
Shoulder x-ray, complete study (minimum of 2 views) [HCPCS 73030]
A radiologic examination of the shoulder is done. The shoulder is the junction of the humeral head and the glenoid of the scapula. Standard views include the anteroposterior (AP) view and the lateral 'Y' view, named because of the Y shape formed by the scapula when looking at it from the side. An axial view can also be obtained for further assessment when the patient is able to hold the arm in abduction. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures.
10% lower than market
Spinal x-ray of upper spine (4 or 5 views) [HCPCS 72050]
Spinal x-ray of upper spine (4 or 5 views) [HCPCS 72050]
A radiologic exam is done of the cervical spine. Anteroposterior and lateral views are the most common projections taken. X-ray uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures.
11% higher than market
Toe(s) x-ray (minimum of 2 views) [HCPCS 73660]
Toe(s) x-ray (minimum of 2 views) [HCPCS 73660]
A radiologic examination of the calcaneus images the bones of the distal lower extremity and usually includes the tibia, fibula, and talus. A radiologic examination of the toe(s) (phalanges) will usually include the metatarsals. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures. The radiographs may be taken to look for the cause of pain, limping, or swelling, or conditions such as fractures, dislocations, deformities, degenerative disease, osteomyelitis, arthritis, foreign body, and cysts or tumors. Calcaneus and toe(s) x-rays may also be used to determine whether there is satisfactory alignment of lower extremity bones following fracture treatment. Standard views to image the calcaneus include lateral (side) and axial (supine with foot dorsiflexed). Common views to image the toe(s) include top to bottom dorsal planter (DP) and oblique (supine with leg rotated medially to image the 1st, 2nd, and 3rd digits and laterally to image the 4th and 5th digits).
7% higher than market
Ultrasound application to 1 or more areas (each 15 minutes) [HCPCS 97035]
Ultrasound application to 1 or more areas (each 15 minutes) [HCPCS 97035]
Ultrasound uses high frequency sound waves applied to produce heat and/or vibration to promote the circulation, reduce inflammation, and improve the flexibility of connective tissue. A water-soluble gel is applied to the site to be treated. A hand-held device is used to deliver the sound waves. The device is moved over the site using a circular motion. Ultrasound is helpful in treating acute soft tissue injures. Ultrasound is a physical therapy modality that requires constant attendance with direct (one-on-one) patient contact. Ultrasound is a time-based service reported in 15-minute increments.
48% lower than market
Wrist x-ray, complete study (minimum of 3 views) [HCPCS 73110]
Wrist x-ray, complete study (minimum of 3 views) [HCPCS 73110]
A radiologic examination of the wrist is done. X-ray imaging uses indirect ionizing radiation to take pictures inside the body. X-rays work on non-uniform material, such as human tissue, because of the different density and composition of the object, which allows some of the x-rays to be absorbed and some to pass through and be captured behind the object on a detector. This produces a 2D image of the structures. The radiographs may be taken to look for conditions such as fractures, dislocations, deformities, arthritis, foreign body, infection, or tumor. Wrist standard views include the front to back anteroposterior (AP) or back to front posteroanterior (PA) projection; the lateral view with the elbow flexed and the hand and wrist placed thumb up; and oblique views. Oblique views are obtained with the hand and wrist either supinated or pronated with the hand slightly flexed so the carpal target area lies flat, and then rotating the wrist 45 degrees externally or internally. A more specialized image may be obtained for assessing carpal tunnel. For the carpal tunnel view, the forearm is pronated with the palm down, and the wrist is hyperextended as far as possible by grasping the fingers with the opposite hand and gently hyperextending the joint until the metacarpals and fingers are in a near vertical position.
11% lower than market
Harbor Regional Health Patient Information Price List
OUTPATIENT PROSTHETIC PROCEDURES
OUTPATIENT PROSTHETIC PROCEDURES
Description
Variance
Prosthetic implant nos [HCPCS L8699]
Prosthetic implant nos [HCPCS L8699]
36% higher than market
Harbor Regional Health Patient Information Price List
OUTPATIENT PULMONARY THERAPY
OUTPATIENT PULMONARY THERAPY
Description
Variance
CPAP (continuous positive airway pressure) mask or breathing tube initiation and management for night time respiratory muscle rest [HCPCS 94660]
CPAP (continuous positive airway pressure) mask or breathing tube initiation and management for night time respiratory muscle rest [HCPCS 94660]
Continuous positive airway pressure (CPAP) ventilation is used primarily to treat sleep apnea. It may also be prescribed to treat preterm infants whose lungs have not fully developed. CPAP uses a mask or other breathing device that fits over the nose and mouth which is connected via a tube to a CPAP device. The CPAP machine delivers an air mixture at a continuous low level of pressure. The continuous positive airway pressure keeps the airways open and prevents mechanical obstruction of the flow of air caused by relaxation and collapse of airway structures during sleep. This code is used for initial set-up and management. A durable medical device provider delivers the CPAP device and other required equipment to the home or a residential facility. The device is set up and programmed to the settings indicated by the written prescription obtained from the physician or other qualified health care professional. The patient or caregiver is instructed on correct use of the CPAP and then is asked to demonstrate understanding by placing the mask over the mouth and nose and turning on the machine.
18% lower than market
Heart and blood vessel stress test with EKG tracing and monitoring (exercise or drug-induced) [HCPCS 93017]
Heart and blood vessel stress test with EKG tracing and monitoring (exercise or drug-induced) [HCPCS 93017]
An ECG is used to evaluate the electrical activity of the heart using treadmill, bicycle exercise, and/or pharmacologically induced stress. Small plastic patches are attached at specific locations on the chest, abdomen, arms, and/or legs. Leads (wires) from the stress ECG device are then attached to the patches. A baseline ECG is obtained. The exercise portion of the study is then initiated. Heart rate and blood pressure are monitored. Staged stress protocol is used and the patient's response to stress is monitored as the stress ECG is recorded. Unless contraindicated, exercise or pharmacological stress continues until the patient is unable to continue or until the target heart rate is achieved. Upon completion of the study, the stress ECG is reviewed and a written interpretation of findings is provided.
27% lower than market
Routine EKG (electrocardiogram) tracing using at least 12 wires [HCPCS 93005]
Routine EKG (electrocardiogram) tracing using at least 12 wires [HCPCS 93005]
An ECG is used to evaluate the electrical activity of the heart. The test is performed with the patient lying prone on the exam table. Small plastic patches are attached at specific locations on the chest, abdomen, arms, and/or legs. Leads (wires) from the ECG tracing device are then attached to the patches. A tracing is obtained of the electrical signals from the heart. Electrical activity begins in the sinoatrial node which generates an electrical stimulus at regular intervals, usually 60 to 100 times per minute. This stimulus travels through the conduction pathways to the sinoatrial node causing the atria to contract. The stimulus then travels along the bundle of His which divides into right and left pathways providing electrical stimulation of the ventricles causing them to contract. Each contraction of the ventricles represents one heart beat. The ECG tracing includes the following elements: P wave, QRS complex, ST segment, and T wave. The P wave, a small upward notch in the tracing, indicates electrical stimulation of the atria. This is followed by the QRS complex which indicates the ventricles are electrically stimulated to contract. The short flat ST segment follows and indicates the time between the end of the ventricular contraction and the T wave. The T wave represents the recovery period of the ventricles. The physician reviews, interprets, and provides a written report of the ECG recording taking care to note any abnormalities.
37% lower than market
Harbor Regional Health Patient Information Price List
INPATIENT CARDIOLOGY
INPATIENT CARDIOLOGY
Description
Variance
Heart Failure with complications
Heart Failure with complications
15% lower than market
Heart Failure with major complications
Heart Failure with major complications
12% lower than market
Harbor Regional Health Patient Information Price List
INPATIENT MEDICINE
INPATIENT MEDICINE
Description
Variance
Blood Infection with major complications
Blood Infection with major complications
15% lower than market
Blood infection without major complications
Blood infection without major complications
17% lower than market
Digestive System Bleeding with complications
Digestive System Bleeding with complications
27% higher than market
Infection of the skin
Infection of the skin
15% lower than market
Nutritional or Metabolic Disorders without major complications
Nutritional or Metabolic Disorders without major complications
14% lower than market
Harbor Regional Health Patient Information Price List
INPATIENT NEUROLOGY
INPATIENT NEUROLOGY
Description
Variance
Stroke with complications
Stroke with complications
17% lower than market
Harbor Regional Health Patient Information Price List
INPATIENT ORTHOPEDIC SURGERY
INPATIENT ORTHOPEDIC SURGERY
Description
Variance
Hip & femur procedures except major joint with complications
Hip & femur procedures except major joint with complications
4% lower than market
Harbor Regional Health Patient Information Price List
INPATIENT PULMONOLOGY
INPATIENT PULMONOLOGY
Description
Variance
Chronic Lung Disease with major complications
Chronic Lung Disease with major complications
20% lower than market
Pneumonia with major complications
Pneumonia with major complications
6% lower than market
Respiratory Failure
Respiratory Failure
3% lower than market
Harbor Regional Health Patient Information Price List
INPATIENT UROLOGY
INPATIENT UROLOGY
Description
Variance
Kidney & urinary Infection without complications
Kidney & urinary Infection without complications
8% higher than market
Kidney failure with complications
Kidney failure with complications
7% lower than market
Harbor Regional Health Patient Information Price List
BILLING PROCESS AND INFORMATION
BILLING PROCESS AND INFORMATION
How You Can Help
Thank you for choosing Harbor Regional Health for your healthcare needs. We want to make understanding and paying your bill as easy as possible. Here are some ways you can help us as we work to make the billing process go smoothly.
• Please give us complete health insurance information.
In addition to your health insurance card, we may ask for a photo ID. If you have been seen at Harbor Regional Health, let us know if your personal information or insurance information has changed since your last visit.
• Please understand and follow the requirements of your health plan.
Be sure to know your benefits, obtain proper authorization for services and submit referral claim forms if necessary. Many insurance plans require patients to pay a co-payment or deductible amount. You are responsible for paying co-payments required by your insurance provider and Harbor Regional Health is responsible for collecting co-payments. Please come to your appointment prepared to make your co-payment.
• Please respond promptly to any requests from your insurance provider.
You may receive multiple bills from your hospital visit, including your family doctor, specialists, physicians that read x-rays, providers that give anesthesia, or physicians that interpret blood work. Insurance benefits are the result of your contract with your insurance company. We are a third-party to those benefits and may need your help with your insurance. If your insurance plan does not pay the bill within 90 days after billing, or your claim is denied, you will receive a statement from Harbor Regional Health indicating the bill is now your responsibility. All bills sent to you are due upon receipt.
Questions about Price and Billing Information
Our goal is for each of our patients and their families to have the best healthcare experience possible. Part of our commitment is to provide you with information that helps you make well informed decisions about your own care.
To ask questions or get more information about a bill for services you've received, please contact our Billing Department at 360-532-8330.
If you need more information about the price of a future service, please contact our Customer Service at 360-532-8330. A physician’s order or CPT code is strongly encouraged when you call to assist us in providing you with the most accurate estimate. You can obtain the CPT code from the ordering physician.
© 2020 Hospital Pricing Specialists LLC - ALL RIGHTS RESERVED.